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ABSTRACT 
The chronic inflammatory disease periodontitis is characterized by destruction of periodontal 
tissue, i.e. the tissues that surround and support the teeth. This complex disease is 
multifactorial, involving oral pathogens, an unfavorable host inflammatory response, 
environmental and genetic factors, as well as an altered gene expression contributing to 
disease pathology. 
Despite extensive research of excellent quality, the genes involved in periodontitis remain 
uncharacterized and the mechanisms responsible for the destruction of periodontal tissue are 
poorly understood. Here, in attempt to gain further insight into and identify biomarkers for 
this disease, we have characterized global gene expression in periodontitis-affected gingival 
tissue and gingival fibroblasts. 
Initially, we employed microarrays to examine gene expression in gingival fibroblasts, the 
predominant cell type in gingival connective tissue, after evoking an inflammatory response 
in these cells with tumor necrosis factor-α (TNF-α). This inflammatory mediator up-regulated 
the expression of a wide range of genes and, furthermore, activated several signaling 
pathways involved in immune and inflammatory responses, in particular the toll-like receptor 
(TLR) signaling pathway. We subsequently confirmed for the first time that TNF-α-enhances 
the expression of TLR2 in gingival fibroblasts at both the mRNA and protein levels. In 
addition, we found that the c-Jun N-terminal kinase (JNK) and nuclear factor-kappa B (NF-
kB) signal transduction pathways, as well as prostaglandin 15d-PGJ2, which has been 
proposed to be anti-inflammatory, are involved in this up-regulation.  
Next, we examined the transcriptome, employing RNA-sequencing, in periodontitis-affected 
and healthy gingival tissue from patients with periodontitis. We demonstrated, as expected, 
that the degree of inflammation in periodontitis-affected gingival tissue is more pronounced 
than in corresponding healthy tissue from the same individual. Cluster analysis revealed that 
the clustering depended on the degree of inflammation, rather than the individual from whom 
the tissue was taken, indicating the existence of a characteristic gene expression profile for 
periodontitis. In addition, we identified two novel genes, interferon regulatory factor 4 (IRF4) 
and Chemokine (C-C motif) ligand 18 (CCL18) that were up-regulated in association with 
periodontitis. 
In our third study, we utilized the RNA-sequencing approach to characterize gene expression 
in a large number of gingival biopsies both from patients with periodontitis and healthy 
control subjects. Among the several genes that were significantly up- or down-regulated in 
periodontitis, the two most differentially expressed were mucin 4 (MUC4) and matrix 
metalloproteinase 7 (MMP7). This investigation provides a comprehensive map of the gene 
expression associated with periodontitis and, suggests that MUC4 and MMP7 might be 
potentially valuable biomarkers and clinical therapeutic targets for periodontitis.  
In conclusion, the information we present here provides new insights into the molecular 
mechanisms underlying the etiology and progression of this chronic inflammatory disease.  
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eriodontitis is a complex chronic inflammatory disease characterized by destruction 
of periodontal tissue. The disease involves numerous features, including altered gene 
expression contributing to disease pathology. Since no genes specifically related to 
this disease have yet been identified, we have employed here sequenced based analysis of the 
transcriptome to explore global gene expression in association with periodontitis, using 
gingival tissue and gingival fibroblasts. 
PERIODONTITIS 
In 1700 researchers began to study two dental health problems they called gingivitis and 
periodontitis, collectively referred to as periodontal diseases and characterized by 
inflammation of the periodontium, i.e. the tissues that surround and support the teeth.1 The 
periodontium is comprised of the cementum of the root surface, the alveolar bone, the 
periodontal ligament, and the gingiva,2-4 divided anatomically into the unattached (marginal) 
gingiva at the terminal edge and with an outer surface, the papilla, and the attached gingiva 
extending apically from the marginal gingiva to eventually merge with the alveolar mucosa. 
Collagen fibers of the connective tissue firmly attach the epithelium of the gingiva to the 
underlying cementum and bone,5 where it covers and protects the alveolar bone and 
surrounding teeth from environmental dangers such as microorganisms and harmful agents. 
This protection was historically thought to be provided simply by the physical barrier, but 
through the years the possibility that gingival epithelial cells play a role in innate immune 
responses to bacteria has been raised.5 
In the early stage of periodontal disease, referred to as gingivitis, inflammation due to poor 
oral hygiene that result in deposit of bacteria as dental plaque is limited to the gingiva.6,7 This 
condition is reversible, through improvement of dental hygiene.8 However, even though the 
gingivitis may remain stable, if the dental plaque continues to irritate the gingiva, in some 
susceptible individuals the inflammation will become chronic and spread to deeper layers of 
the periodontium.9 This process may in turn lead to destruction of the structures supporting 
the teeth, including the gingival tissue and underlying alveolar bone, a condition referred to as 
periodontitis.9  
In the case of periodontitis, the periodontal ligament that attaches the gingiva and the alveolar 
bone to the cementum may detach during the inflammatory response to destructive stimuli 
such as lipopolysaccharide LPS, toxins and enzymes released by pathogens.10 In susceptible 
individuals, inflammation can become chronic, leading to the formation of a pocket next to 
the tooth that exposes the cementum of the root surface and permits bacteria to accumulate, 
causing these same pockets to deepen and destroy underlying supporting tissues. If the 
disease becomes severe, teeth will loosen, become painful and eventually be lost.2,4,11 
Although only approximately 5-20% suffer from severe periodontitis, the mild to moderate 
form can afflict most adults.12-15 However, it must be emphasized that this prevalence 
P
 4 
depends on the type of periodontitis, as well as the population involved.13,16 The frequency 
increases with age17,18 and men have been reported to be more susceptible than women.19  
During the past four decades, the complex multifactorial nature of periodontitis has become 
obvious. Thus, accumulation of bacteria alone is no longer considered sufficient to initiate the 
disease, since individuals are not equally susceptible to and differ in their responses to 
bacterial infections. Oral pathogens, an unfavorable host inflammatory response, and other 
environmental and genetic factors are all now thought to be risk factors (Figure 1).2,20,21 For 
example, several twin studies have revealed that inherited factors are involved in more than 
half of the cases of periodontal disease.22-24 Furthermore, several investigations have shown 
that not only are smokers more likely to develop periodontitis than non-smokers,25,26 but they 
also tend to develop more severe disease with more extensive tooth loss.25 Moreover, 
smoking attenuates the response to periodontal treatment.27 Recently, it was also suggested 
that oral pathogen communities, involved in periodontitis, do not only mediate inflammation 
at local sites but also affect systemic health.28 Associations between periodontitis and 
systemic diseases such as diabetes mellitus,29,30 rheumatoid arthritis,31-33 cardiovascular 
diseases,34,35 osteoporosis,36 and obesity37 have been proposed, suggesting that preventing and 
treating periodontitis may also improve these conditions.36,38  
In summary, the key determinant of periodontitis is the complex interplay between microbial 
challenge and the subsequent host immune response, described below, in addition to 
modifying factors mentioned above.20,28 
Microbial challenge 
Although bacterial plaque is required for initiation of gingivitis and periodontitis, the aerobic 
and anaerobic bacterial species present in the oral cavity, estimated to be more than 700 in 
number,6,39 live essentially in symbiosis with the healthy host,2 as they do on other external 
surfaces of the body and in the gut. Bacterial species adhere to and form highly organized 
biofilms on various oral sites, including the tooth surface and gingival margins. Each biofilm 
is a complex community containing a variety of microorganisms, facilitates the adhesion of 
other bacteria and produces an extracellular polysaccharide matrix that protects the 
microorganism community from the surrounding environment.40  
During the development and progression of periodontitis, bacterial plaque accumulates 
deeper in the periodontal pocket, a more anaerobic environment, where the composition of 
the biofilm changes from primarily Gram-positive bacteria to more harmful anaerobic and 
Gram-negative bacteria, including the “red complex” pathogens, Porphyromonas gingivalis 
(P.gingivalis), Tannerella forsythia and Treponema denticola.41-43 The red complex, the most 
virulent organisms present at diseased sites, is associated with more advanced periodontal 
disease.43 These pathogens release tissue-degrading enzymes such as collagenases, 
fibrinolysins and other proteases, as well as other harmful bacterial products, including LPS, 
lipothetic acids and peptidoglycans collectively termed Pathogen-Associated Molecular 
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Patterns (PAMPs).44-46 The presence of pathogens and their harmful products evokes an 
inflammatory response by the host designed to eliminate the microbial challenge. 
 
 
Host immune response 
Toll-like receptors 
The first step in the host immune response, i.e., recognition of PAMPs, expressed on or 
released by invading pathogens,47,48 is accomplished by toll-like receptors (TLRs) on the 
plasma membrane. To date, 10 and 12 functional TLRs that recognize specific ligands have 
been identified in humans and mice, respectively.48-50 Upon ligand binding these receptors 
initiate a cascade of signaling pathways leading to the production and release of chemokines 
and adhesion molecules that lead to migration of neutrophils and production of mediators that 
initiate an inflammatory response.51,52  
Two types of signaling pathways are involved, one dependent on and the other independent 
of the myeloid differentiation primary response protein 88 (MyD88). While most TLRs act 
via the dependent pathway, stimulation of TLR3 and TLR4 instead activates interferon-
regulatory factor 3 (IRF3).53,54 Upon ligand binding to TLRs, MyD88 recruits interleukin-1 
receptor associated kinase 1 (IRAK1) to induce the mitogen-activated protein kinase kinase 
 6 
kinase (MAP3K), which in turn activates the mitogen-activated protein kinases (MAPKs), c-
Jun N-terminal kinases (JNK) and p38, as well as the transcription factor nuclear factor-
kappa B (NF-ĸB). This process results in the inflammatory response designed for pathogen 
clearance.  
TLRs are expressed predominantly on the surface of cells of the innate immune system, 
including neutrophils, monocytes/macrophages and dendritic cells. However, cells of the 
periodontium, including epithelial cells and gingival fibroblasts also express these receptors 
and thereby participate in the innate immune response against bacteria that cause dental 
plaque.51 It has been proposed that gingival epithelial cells express TLRs, as a result of 
constantly being exposed to bacterial PAMPs.51,55 In addition, gingival fibroblasts express 
TLR2 and TLR4 upon exposure to LPS from P.gingivalis.56,57  
The inflammatory response  
Recognition of PAMPs by TLRs on inflammatory and resident cells of the gingiva, including 
fibroblasts, evokes an immediate inflammatory response involving the production of 
cytokines and chemokines that recruit appropriate cells to the site of infection.7,20,58 The 
subsequent cascade of events is designed to meet the microbial challenge. Vasoactive 
amines and preformed tumor necrosis factor-α (TNF-α) are released by mast cells, thereby 
increasing vascular permeability so that components of the blood can enter the connective 
tissue. These mediators also up-regulate expression of adhesion molecules such as 
intercellular adhesion molecule-1 (ICAM-1) on the surface of endothelial cells.7,44  
The enhanced vascular permeability allows polymorphonuclear leukocytes (PMNs) to enter 
the tissue, where they release lysosomal enzymes that degrade connective tissue.7 By this 
time, lymphocytes (mainly T-cells) and macrophages have also begun to invade the tissue 
and release pro-inflammatory mediators, including interleukin-1β (IL-1β), TNF-α, and 
prostaglandins, as well as hydrolytic enzymes such as matrix metalloproteinases (MMPs). 
Together, these processes degrade 60-70% of the collagen of the connective tissue at the 
affected site, but this does not necessarily result in permanent damage, since the gingival 
tissue can repair and remodel with the alveolar bone still intact.4,7 However, if the 
inflammation fails to resolve and becomes chronic, with a B-cell/plasma cell response, 
additional connective tissue and even alveolar bone can be lost.7 Thus, although this initial 
immune response to a microbial challenge in periodontal tissue is a physiological defense 
mechanism, in certain individuals with greater susceptibility and/or exposure to unfavorable 
environmental factors, the inflammation becomes chronic and pathological. 
Inflammatory mediators 
Even though the release and production of pro-inflammatory mediators in periodontitis is 
initially protective, the majority of the tissue damage that characterizes the clinical signs of 
the disease is derived from the prolonged and excessive production of various mediators. 
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These mediators include cytokines and chemokines, proteolytic enzymes (MMPs), as well 
as prostaglandins, which all play a major role in the pathogenesis of periodontitis.45  
Cytokines play essential roles in several physiological processes, but can also promote 
pathological processes if the balance between pro- and anti-inflammatory cytokines tips 
towards pro-inflammatory, as occurs in periodontitis. In the periodontium, cytokines are 
produced by invading inflammatory cells (neutrophils, macrophages and lymphocytes), as 
well as by resident cells of the gingiva (epithelial cells and fibroblasts).45,59 The pro-
inflammatory cytokines implicated in the pathogenesis of periodontitis include IL-1, IL-6, 
IL-12, IL-17, IL-18, IL-21, TNF-α and interferon gamma, with IL-1β and TNF-α appearing 
to play pivotal roles.45,59,60  
TNF-α is crucial for the initiation of an inflammatory response and, ultimately, tissue 
destruction.59,61 This cytokine is produced and secreted at a very early stage by mast cells, 
but as the inflammatory process progresses, several other types of cells, including PMNs, 
macrophages, epithelial cells, fibroblasts, endothelial cells and osteoclasts also start to 
produce and secrete TNF-α.45,59 TNF-α promotes the expression of adhesion molecules, 
chemokines and MMPs, prostaglandin E2 (PGE2) production, and osteoclast formation.59 The 
levels of this pro-inflammatory mediator in gingival crevicular fluid (GCF) and gingival 
tissue at sites of periodontitis is elevated62-64 and, moreover, anti- TNF-α-treatment has been 
reported to reduce loss of tooth attachment in patients with periodontitis and subsequent 
rheumatoid arthritis.65 
Chemokines are chemotaxic cytokines produced by a variety of cells, including endothelial, 
epithelial and stromal cells, fibroblasts, as well as leukocytes.66 In connection with the 
inflammatory response, chemokines promote migration of phagocytic cells to the site of 
infection, as well as other relevant processes such as angiogenesis, cell proliferation, and 
apoptosis.67,68 The two key chemokines of the innate immune system are IL-8 and monocyte 
chemoattractant protein-1 (MCP-1), also known as chemokine (C-C motif) ligand 2 
(CCL2).69 Synthesized by gingival fibroblasts, gingival epithelial cells, as well as endothelial 
cells in the periodontium in response to IL-1, TNF-α and LPS, IL-8 acts as a chemoattractant 
for PMN leukocytes.70-72 The level of this chemokine in gingival tissue at sites of 
periodontitis, characterized by large numbers of PMN cells, is elevated.73 MCP-1 initiates 
and regulates mobilization of monocytes to active sites of severe periodontal 
inflammation,69 and its expression in the gingival tissue of patients with periodontitis is 
enhanced.74,75 Furthermore, the  level of MCP-1 in GCF from patients with chronic 
periodontitis is elevated.76 
The large family of MMP endopeptidases degrades extracellular matrix molecules such as 
collagen and proteoglycans and thereby participates in tissue remodeling. These enzymes 
are expressed by several cells of the periodontium, including fibroblasts, keratinocytes, 
osteoblasts, endothelial cells, macrophages, and neutrophils.60,77,78 In healthy gingival 
tissue, collagen homeostasis is maintained by endogenous tissue inhibitors of 
metalloproteinases (TIMPs),77,78 which regulate the expression of MMPs, primarily by 
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fibroblasts.79 In inflamed periodontal tissue, several resident cells and inflammatory cells 
(particularly neutrophils) secrete excessive levels of MMPs, thereby disrupting the balance 
and resulting in degradation of connective tissue. Several MMPs have been shown to be 
associated with periodontitis, in particular MMP2, MMP8 and MMP9.80,81 For example, the 
levels of MMP8 and MMP9 in GCF and gingival tissue are reported to be directly 
correlated to the severity of disease.82-84 
Prostaglandins, additional important mediators of host inflammatory responses, are 
synthesized from the long-chain arachidonic acids by inflammatory cells, as well as by 
fibroblasts and other cells resident in the gingival tissue. Among prostaglandins, PGE2 
plays a major role in the pathogenesis of periodontitis,85,86 being present at elevated levels 
in the gingival tissue and GCF of patients with this disease. PGE2 induces secretion of 
MMPs and stimulates formation of osteoclasts through the receptor activator of NF-ĸB 
ligand (RANKL), which is also associated with periodontal tissue destruction.85,87 
GENE EXPRESSION 
In 1956 Francis Crick formulated the Central dogma of molecular biology, describing the 
flow of genetic information from DNA to a gene product. This process occurs in two steps: 
DNA is first transcribed into messenger RNA (mRNA), which then serves as a template for 
protein synthesis during translation. Whereas the genetic information, the genome, is the 
same in every cell of a given organism (with the exception of gametes), the mRNA and 
protein profiles, i.e., the transcriptome and proteome, vary between cells.  
The term gene expression refers to the process of transferring the information from a gene 
to mRNA and then decoding this information to make a protein. The patterns of gene 
expression in a cell or tissue depend on its developmental stage, function or disease state 
and determination of the profile of the mRNA molecules present can provide insights into 
the mechanisms underlying pathological processes. For example, gene expression profiling 
provides a tool for answering a wide range of questions, including how active various genes 
are in different types of cells or tissues, how gene expression levels change under different 
conditions, and how genes are “differentially expressed” between diseased and healthy 
tissues. In the following sections of this thesis, gene expression will be monitored at the 
mRNA level. 
Techniques for studying gene expression 
Over the years, analysis of gene expression has undergone major advances, from the first 
northern blot to the development of the polymerase chain reaction (PCR) and high-
throughput procedures, including microarrays and massive parallel sequencing, leading 
researchers to investigate gene expression at a level never possible before. The choice of 
approach depends intimately on the questions being asked. In biological systems where the 
genes of interest are not yet known, primary characterization is usually performed 
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employing high-throughput technology. However, for investigating many samples where 
the key genes of interest have been identified, more targeted techniques, such as PCR, are 
commonly used. 
PCR, the cornerstone of the human genome project, was developed by Kary Mullis almost 30 
years ago, winning him the Nobel Prize for chemistry in 1993.88-90 PCR technology is best 
suitable for measuring the expression of few genes in a large number of samples.91 Reverse 
transcriptase-PCR (RT-PCR) provides qualitative gene expression profiling through the 
construction of cDNA transcripts from RNA during the final phase of the reaction. In contrast 
quantitative real-time-PCR or qPCR, the most sensitive technique for quantifying mRNA 
levels and often considered the gold standard,91 utilizes fluorescent probes to quantify the 
amplification of DNA during the early phases of the reaction. Among the distinct advantages 
of qPCR,92,93 is its more extensive dynamic range of detection (capable of revealing as little 
as 2-fold change), in contrast to the 10-fold changes detectable on the agarose gels used in 
RT-PCR. Furthermore, qPCR data are expressed directly as numbers, eliminating the post-
processing required with RT-PCR.92 The PCR technology has been widely used for research 
purposes, as well as for detection of pathogens, and diagnosis of genetic disorders.  
In the present work we have applied both targeted techniques, such as RT-PCR, and high-
throughput methodology, including microarrays and RNA sequencing (RNA-seq) (see further 
below). 
Microarrays 
In 1995 Patrick Brown and colleagues at Stanford University first brought attention to the 
exciting potential of using microarray technology to determine the expression of numerous 
genes at the same time.94-96 A microarray is a glass or silicon slide or chip on which are 
immobilized 500-30 000 complementary DNA (cDNA) fragments (usually as long as 1500 
bp) or oligonucleuotides (usually 70-mers), often several for each gene being analyzed.97 
Typically, mRNA is first isolated from two samples to be compared (e.g. healthy and 
periodontitis sample from the same individual) and subsequently reverse transcribed by RT-
PCR to generate cDNA. The two samples of cDNA are then labeled individually with 
different fluorescent dyes e.g. Cyanine (Cy; Cy3 and Cy5), pooled and cohybridized onto the 
arrays, from which a dual colour image is finally obtained by scanning (Figure 2).94 Since 
microarray analysis provides only the relative levels of different mRNAs, Northern blot and 
qPCR are commonly applied to confirm the data obtained.  
The microarray approach is a rather simple, inexpensive but robust means of examining the 
expression of thousands of genes at once and we employed this technique in Study I to 
characterize the mRNA profile of human gingival fibroblasts with and without exposure to 
TNF-α this choice was based on our previous experience with microarrays, as well as the 
considerable collective experience concerning normalization and interpretation of the data 
thus obtained. The deep-sequencing technology, discussed below, was at that time relativly 
new and required extensive validation and advanced tools for data analysis. 
 10 
 
 
Massive parallel sequencing, RNA sequencing 
In 2009, a novel deep-sequencing technology, termed RNA-sequencing (RNA-seq) 
revolutionized transcriptome analysis. Unlike microarray technology, RNA-seq does not 
require labeling with dyes or designing probes with a pre-defined set of sequences,98,99 thus, 
allowing global characterization of the transcriptome.97,98 Of the several systems presently 
available for RNA-seq including Illumina IG18,100-102 Applied Biosystems SOLiD103 and 
Roche 454 Life Science,104-106 the Illumina sequencer is most commonly used.107 
RNA-seq has considerable potential to eventually replace microarrays for gene expression 
profiling. In addition to its independence from knowledge of reference transcriptomes, RNA-
seq is more reproducible, involves lower background signals and less technical variation, and 
covers a wider range of expression levels.108,109 Moreover, this approach can identify novel 
gene transcripts, novel isoforms, allele-specific expression and alternative splicing 
variants.110,111 However, many research groups still use microarrays, which are cheaper, and 
do not require the extensive bioinformatics skills and computer resources needed for the 
retrieval, storage and processing of the large amounts of data provided by RNA-seq.98,112  
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In practice, RNA is isolated from a sample and purified; converted to a library of cDNA and 
fragmented; and adaptors attached to these fragments, which are then amplified and 
sequenced for short distances from one (single-end sequencing), or both ends (pair-end 
sequencing) (Figure 3).112 The millions of short reads generated can be mapped to a reference 
genome and the number of reads that align to each individual gene, referred to as “counts”, 
provides a digital measurement of the level of gene expression.113 
 
 
Analysis of sequencing data 
Once reads are generated through RNA-seq, gene regions that match read sequences are 
identified and the total number of reads that map onto each gene provides an estimate of the 
level of gene expression (counts). Normalization is then performed to eliminate possible 
biases and allow reliable comparison between and within samples, which is absolutely 
necessary for differential gene expression analysis.112-114 Differential gene expression 
analysis allows identification of genes whose levels of expression differ in two samples, and 
thus might play a potential role in, e.g. the pathology of a disease.113 A 2-fold difference is 
usually considered to be a reasonable cutoff.113,115 
The next step in the data analysis is to perform enrichment analysis. Enrichment analysis 
helps to interpret the mass of transcriptome profiling data generated by array and sequencing 
analysis, facilitating the discovery of possible associations and interactions of differentially 
expressed genes.116 With this approach genes are mapped, e.g. to their related biological 
categories in Gene ontology (GO)117 or components of pathways in Kyoto Encyclopedia of 
Genes and Genomes (KEGG),118 and compared with the background distribution for 
statistical over- or under-representation.119 By searching different databases, the GO project 
attempts to categorize all known genes according to their involvement in biological process, 
molecular functions, and cellular localization.117  
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Thus, enrichment analysis helps answer biological questions such as: is a disease phenotype 
characterized by a specific profile of differentially expressed genes? Which 
cellular/molecular pathways might be involved in the pathological process? Can any single 
gene or set of genes predict severity and/or outcome? And in the long run, can these findings 
be applied in clinical practice? A schematic overview of the steps included in the RNA-seq 
data analysis process is illustrated in Figure 4. 
 
 
Microarray analysis in periodontitis- previous studies 
In gingival tissues 
Several research groups have investigated the gene expression profile in patients with 
periodontitis.120-124 For example, in 2008 Demmer and co-workers121 carried out a 
microarray-based whole tissue transcriptome study that demonstrated significant changes in 
the gene expression of genes related to 61 pathways, including apoptosis, antimicrobial 
humoral response, antigen presentation, regulation of metabolic processes, signal 
transduction, and angiogenesis, in papillae from diseased and healthy sites from patients with 
advanced periodontitis.121 The same group attempted in 2013 to find a molecular difference 
between chronic and aggressive periodontitis based on the gingival transcriptome. However, 
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their microarray study could not differentiate between the two forms of periodontitis,123 but in 
2014 on the basis of these same microarray data they proposed that distinct transcriptome 
profiles in pathologic gingival tissues reflect phenotypic differences and might provide a 
basis for a novel classification of the disease.124  
In 2008 Beikler and colleuges125 used microarrays to examine a selected number of 
inflammatory genes and found that following therapy of periodontal tissues the activities of 
biological pathways responsible for tissue damage and regulation of repair were higher, 
while the expression of immune and inflammatory genes was lower than in healthy 
controls.125 However, in light of individual variations in gene expression and the fact that 
the control tissues were not from the same patients, their study population of 11-12 
individuals was small and the results should therefore be interpreted with caution. 
In gingival cells  
In vitro efforts have been made to characterize the gene expression profiles of different cell 
populations from the gingiva. In 2003, Wang et al.126 employed microarray analysis, to 
demonstrate that eight different genes, including the pro-inflammatory cytokines IL-1β, IL-6, 
IL-8, and TNF-α, were more highly expressed in fibroblasts from inflamed than healthy 
gingiva.126 To further evaluate the role of the pro-inflammatory cytokine TNF-α in this 
context, Båge and colleges127 utilized microarray analysis to reveal that the signal 
transduction pathways NF-ĸB and JNK are positively regulated by TNF-α in gingival 
fibroblasts and that inhibition of these pathways attenuates the expression of prostaglandins. 
These researchers concluded that these two pathways are potential targets for inhibiting the 
chronic inflammation involved in periodontitis.127  
Using an epithelia-specific cDNA microarray to analyze gene expression in human gingival 
keratinocytes stimulated with IL-1β in vitro, Steinberg and co-workers128 showed that 
several genes involved in pathways such as cell stress, DNA repair, cell cycle and 
proliferation, anti-pathogen response, extracellular matrix turnover, and angiogenesis were 
differentially expressed.128 Furthermore, when Papapanou and co-workers,129 characterized 
mRNA levels in peripheral blood isolated from patients being treated for periodontitis, 
approximately 1/3 exhibited substantial increases in the expression of genes associated with 
innate immunity, apoptosis and cell signaling. The authors concluded that periodontal 
therapy might involve anti-inflammatory changes.129  
In conclusion, despite much research of excellent quality, the broad spectrum of genes 
involved in periodontitis remains uncharacterized and the mechanisms responsible for the 
destruction of periodontal tissue are still poorly understood. Here we focus on determining 
the transcriptome of periodontitis utilizing RNA-seq technology, in attempt to increase the 
knowledge of underlying mechanisms and identify putative biomarkers for the disease. 
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AIMS OF THE PRESENT THESIS 
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he general aim of this thesis was to identify genes involved in periodontitis, through 
whole transcriptome analysis of gingival tissue and gingival fibroblasts. Revealing 
its global gene expression profile and interactions between associated genes can 
better our understanding of the pathogenesis of this complex chronic inflammatory disease. 
STUDY I 
Study I was designed to characterize the effects of the pro-inflammatory cytokine TNF-α on 
the expression and regulation of TLR2 in human gingival fibroblasts. Subsequently, 
microarrays were used to explore the involvement of various signal transduction pathways in 
this context. 
STUDY II 
Study II investigated the gene expression profile of diseased and healthy gingival tissues from 
patients with periodontitis, utilizing RNA-seq. 
STUDY III 
The aim of Study III was to map the gene expression pattern in gingival tissue from a large 
cohort consisting of both patients with periodontitis and healthy controls. Furthermore, we 
confirmed that the differentially expressed mRNAs reflected changes at the protein level as 
well, thereby identifying potential biomarkers and therapeutic targets for periodontitis. 
T
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MATERIALS AND METHODS 
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his section presents an overview of the study design, recruitment of the study 
population and techniques employed with special emphasize on gene expression 
profiling. For more detailed protocols, the reader is referred to the Materials and 
Methods sections of Studies I-III.  
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ETHICAL CONSIDERATIONS 
All the studies were performed in accordance with the principles for medical research as 
formulated in the Declaration of Helsinki and current legislation in Sweden. Collection of the 
gingival biopsies was pre-approved by the Regional Ethics Board in Stockholm. Written 
informed consent was obtained from the patients with periodontitis, as well as from the 
healthy control subjects, prior to enrollment in the studies.  
STUDY DESIGN 
The design of our project, the main purpose of which was to examine gene expression pattern 
in connection with periodontitis, is illustrated schematically in Figure 5. The project began 
with the establishment of an in vitro model using gingival fibroblasts from periodontally 
healthy subjects, in which the gene expression profile was characterized utilizing microarray 
technology in Study I. In the next two studies (II and III), we used RNA-seq to investigate 
gene expression in gingival tissue biopsies both from patients with periodontitis, as well as 
from healthy control subjects. Genes that were up-regulated in cells and gingival tissue 
biopsies where examined further at the protein level, by flow cytometry and 
immunohistochemical analysis. 
GINGIVAL FIBROBLASTS (STUDY I) 
Study I involved cultures of human gingival fibroblasts established from biopsies obtained 
from 5 healthy individuals 6-12 years of age with no clinical signs of periodontal disease. 
Minced gingival tissue was explanted to tissue culture flasks containing culture medium 
supplemented with penicillin and by trypsinization gingival fibroblasts were obtained and 
grown at 37°C under 5% CO2 and subjected to 4-10 passages before use. The cells were 
seeded onto Petri dishes in culture medium supplemented with 5% fetal calf serum, cultured 
for 24 h at 37° C, and then exposed to the pro-inflammatory cytokine TNF-α in the absence 
or presence of various effectors of intracellular signaling pathways. Control cells remained in 
culture medium alone. After incubation for different periods, the cell monolayer was rinsed 
and the cells collected for microarray, RT-PCR or flow cytometric analysis. 
GINGIVAL TISSUE BIOPSIES (STUDIES II AND III) 
The study population 
Gingival bleeding, radiographic assessment of bone loss, clinical attachment level, and 
probing depth have traditionally been the basic clinical criteria for diagnosis of 
periodontitis.130 Using these criteria, 10 patients diagnosed with periodontitis were recruited 
for Study II and 62 patients diagnosed with periodontitis for Study III (Figure 6). All 
demonstrated at least one tooth site with a probing depth ≥ 6 mm, a clinical attachment level 
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≥ 5 mm, as well as bleeding upon probing. None of these patients used nicotine or nicotine-
replacement medications.  
A total of 62 subjects were also included in the healthy control group for Study III (Figure 6). 
These individuals were recruited in connection with implant surgery for tooth loss due to 
reasons other than periodontitis (e.g. caries, accidents, etc.), which gave us the possibility to 
collect biopsies at the same time. The inclusion criteria were lack of any signs of periodontal 
disease, i.e. no sites with gingival/periodontal inflammation, a probing depth ≤ 3.0 mm, a 
clinical attachment level ≤ 3.5 mm and no bleeding upon probing. None of these subjects 
used nicotine or nicotine-replacement medications either. 
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Collection of biopsies 
In Study II both periodontitis-affected tissue and healthy tissue were collected from each 
individual. In connection with flap surgery, two gingival biopsies were collected from a 
periodontal pocket affected by periodontitis, and two other biopsies of about the same size 
(approximately 2x2 including the connective tissue and epithelium) from a clinically healthy 
gingival pocket (i.e. no gingival/periodontal inflammation, no bleeding upon probing, a 
probing depth ≤ 3.5 mm and a clinical attachment level ≤ 3.5 mm) (Figure 7). One biopsy 
from each site was stored in RNA Later for gene expression analysis and the other subjected 
to histological and immunohistochemical analysis. 
 
 
Next, in Study III we examined the gene expression profile in 62 patients with periodontitis 
and 62 healthy individuals. Of the two gingival biopsies of about the same size collected at 
the same site in each participant, one was stored in RNA Later and the second fixed in 
formalin and embedded in paraffin. 
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Histological staining of biopsies 
To assess the degree of inflammation, the quality, as well as the orientation of the epithelium 
and connective tissue of the gingival biopsies in Studies II and III, traditional histological 
staining with hematoxylin and eosin (H&E) was performed. The deep blue-purple 
hematoxylin stains nucleic acids, while pink eosin stains proteins non-specifically. 
Accordingly, in a typical tissue, nuclei are stained blue, while the cytoplasm and extracellular 
matrix exhibit varying degrees of pink staining. The degree of inflammation in all gingival 
biopsies was scored on a relative scale from 0-3 by three “blinded” observers. Furthermore, 
infiltration as by T-cells, B cells and macrophages was determined more specifically using 
traditional immunohistochemical techniques involving commercial antibodies directed 
against cluster of differentiation (CD) 3, CD20 and CD68, respectively. 
GENE EXPRESSION ANALYSES (STUDIES I-III) 
Reverse transcription-PCR (RT-PCR)  
In Study I RT-PCR was applied to investigate the expression of TLR2 in TNF-α- stimulated 
gingival fibroblasts. After 6 h of treatment, RNA was isolated and subjected to reverse 
transcription (Superscript II, 1.0 µg total RNA in a total reaction volume of 20 µl). TLR2 
cDNA was amplified by PCR (5.0 µl cDNA, AmpliTaq Gold DNA polymerase, final 
reaction volume of 50 µl), as were the control GAPDH cDNA and negative controls without 
cDNA. Thereafter, 10 µl of each PCR reaction product was run on an agarose gel containing 
a safe fluorescent nucleic acid dye (GelRed) together with a DNA-ladder standard and the 
intensity of the bands obtained quantified using the Chemidoc XRS molecular system. 
Microarray analysis 
To gain more global insight into the gene expression profile of TNF-α-stimulated fibroblasts, 
microarray analysis was also performed in Study I. Fibroblasts from three different patients 
were analyzed at four different time-points. The microarray chip employed, printed at the 
KTH core facility, contained 35,344 70-mer probes representing 28,948 Entrez Gene IDs,131 
of which 17,972 are unique. RNA was isolated from cultured gingival fibroblasts treated with 
the pro-inflammatory mediator TNF-α for 1, 3 or 6 h utilizing the commercially available 
RNeasy Mini Kit and then quantified and tested for purity spectrophotometrically at 260/280 
nm. cDNA was synthesized using Superscript III and random hexamer primers and then 
labeled with the fluorophore Cy3 (control cells, green) or Cy5 (TNF-α-stimulated cells, red). 
After confirming successful labeling and determining the fluorophore concentrations with a 
Nanodrop instrument, these concentrations were used to obtain equal amounts of sample. 
The microarray chips were pre-hybridized with a buffer containing bovine serum albumin, 
the Cy3- and Cy5-labeled samples pooled and hybridization buffer added. The arrays were 
hybridized overnight at 42° C in a water bath and after washing, immediately scanned on a 
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Agilent G2565BA scanner. The GenePix 5.1.0.0 software was used to extract the raw signals 
from the TIFF images and to assign each spot an ID. The data were analyzed with different 
packages in the R software.132 For low-resolution analysis, the raw data from GenePix was 
transferred into the R software, the spots filtered for removal of abnormal physical 
properties, and the slides subjected to print-tip Lowess normalization. For estimation of the 
M-value (i.e. log2 of the fold-change, e.g. the level of mRNAs in TNF-α–treated 
cells/untreated cells) and variance for each gene, a linear model in the Bioconducter 
package133 LIMMA (Linear models for microarray data) was established. Subsequently, 
differentially expressed genes were identified utilizing a moderated t-test,134,135 with 
application of a false discovery rate algorithm to the calculated p-values to correct for 
multiple testing.136 Thereafter, differentially expressed genes were defined as those with a q 
value < 0.05 (the false discovery rate analog of a p-value) so that the proportion of false 
positives among these genes was 0.05. 
RNA sequencing (RNA-seq) analysis 
In Studies II and III the gene expression profile of gingival biopsies was characterized by 
deep high-throughput sequencing using the Illumina HiSeq 2000 sequencer. The biopsies 
were homogenized and lysed, to enable isolation of stable RNA and this RNA was then 
purified and treated with DNase to degrade contaminating DNA. The quality of the RNA 
thus obtained was assessed using the Agilent Bioanalyzer system. 2-3 µg tissue with an 
RNA integrity number (RIN) >7 was used for the preparation of RNA employing reagents 
either from the Illumina mRNA Sample Preparation Kit or from vendors specified in the 
mRNA sample preparation protocol. The clustering of the bar-coded samples was performed 
on a cBot Cluster Generation System using an Illumina HiSeq Single Read Cluster 
Generation Kit. The library preparations were sequenced on an Illumina HiSeq 2000 as 
single-reads to 100 bp. Two sequencing runs were performed, where two and three lanes 
were used in the first and second sequencing runs, respectively.  
In Study II, these runs generated 402 million reads (an average of 15 million reads per 
sample) that passed through the Illumina Chastity filter, while in Study III 40.2 million 
paired-end reads were obtained per sample. All sequences obtained were aligned to the 
human genome reference hg19 with TopHat version 1.1.4 and Samtools version 0.1.8 and 
annotations from Ensembl and RefSeq applied to assign features to genomic positions and 
these features counted using HTSeq version 0.4.6 with parameters -m intersection-strict -s no 
-t exon. The R/Bioconductor DESeq package was employed to identify differential gene 
expressions among the read counts generated by HTSeq and to perform hierarchical 
clustering of the samples. All replicates for the periodontitis-affected and healthy biopsies 
had R2 (Spearman) correlation of gene expression (read counts) > 0.92. 
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Functional analyses of the transcriptome data 
To determine the category to which genes belonged and discover the pathways related to the 
differentially expressed genes in Studies I and III, enrichment analysis was performed  with 
the GO117 and Wiki pathways databases, by the WEB-based gene set analysis toolkit v2.137 In 
Study III, however, the Database for Annotation, Visualization and Integrated discovery 
(DAVID)119 was used instead. 
PROTEIN EXPRESSION ANALYSES (STUDIES I-III) 
Flow cytometry 
In Study I flow cytometry was applied to quantify expression of the TLR2 protein in TNF-α-
stimulated gingival fibroblasts. The cells were seeded into Petri dishes and grown as 
described above, incubated with TNF-α, collected by trypsinization and stained with a 
monoclonal anti-human TLR2 antibody, followed by a secondary goat anti-mouse IgG 
antibody labeled with fluorescein isothiocyanate. After resuspension of the cells in 
phosphate-buffered saline, cell surface expression of TLR2 was assessed in a FACSCalibur™ 
flow cytometer. 
Immunohistochemical analyses 
To determine whether the elevated levels of interferon regulatory factor 4 (IRF4), CCL18, 
mucin 4 (MUC4) and MMP7 mRNA observed in Studies II and III corresponded to changes 
at the protein level, we performed immunohistochemical analyses using commercially 
available antibodies of appropriate specificity. For additional details see Papers II and III. 
STATISTICAL ANALYSES (STUDIES I-III) 
For statistical analyses other than those employed for the microarray and RNA-seq data (see 
above), we used Student’s t-test (two-tailed), Fisher’s exact test, and the Standard score 
(more commonly referred to as a Z-score). All of the experiments with cell cultures in Study I 
were carried out in triplicate and reproducible data from at least one of these three 
independent experiments are presented. The results are expressed as means ± standard 
deviations and P-values less than 0.05 were considered to be statistically significant. 
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RESULTS AND DISCUSSION 
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n the following sections a brief overview of the results from the three studies will be 
given and discussed in relationship to the current literature. Studies I and II have been 
published in peer-reviewed journals and are reproduced in their entirety in the appendix. 
Study III is a manuscript that has been submitted for publication. 
STUDY I 
The gene expression profile of gingival fibroblasts 
Utilizing microarrays, we explored the global gene expression profile of gingival fibroblasts, 
the most abundant cells in gingival connective tissue, with and without stimulation by the 
pro-inflammatory mediator TNF-α. TNF-α induced the expression of a wide range of genes, 
several of which were related to signaling pathways involved in immune and inflammatory 
responses. The genes up-regulated significantly included those encoding TNF-α, TLR2, 
TLR3, MyD88, mitogen-activated protein kinase kinase kinase 8 (MAP3K8), inhibitor of 
nuclear factor kappa-B kinase subunit epsilon (IKBKE), MAP3K, signal transducers, 
activators of transcription 1 (STAT1), and cytosolic phospholipase A2 (cPLA2). Enrichment 
analysis of the differentially expressed genes indicated significant regulation of several 
signaling pathways, including the TLR pathway.  
TNF-α induces TLR2 expression in gingival fibroblasts 
Gingival fibroblasts, which play a pivotal role in defending against infectious diseases, 
express TLR2 mRNA constitutively.56 This TLR2 recognizes primarily Gram-positive 
bacteria, peptidoglycan, and bacterial lipopeptides,138 but studies have reported that TLR2 
also binds LPS derived from the Gram-negative bacteria, P.gingivalis, commonly associated 
with periodontitis.139-141 Binding of TLRs to their respective ligands triggers signaling events 
that lead to induction of various pro-inflammatory mediators, including TNF-α. Although 
TLRs normally help protect against pathogens, their aberrant expression and/or activation 
might destroy or compromise immune responses, a situation seen in periodontitis.  
Since we had observed that TNF-α elevated the levels of TLR2 mRNA, which could 
conceivably sensitize gingival fibroblasts to pathogen-derived factors, we wished to examine 
the levels of the corresponding protein. After stimulating gingival fibroblasts in vitro with 
TNF-α, we confirmed for the first time, utilizing RT-PCR and flow cytometry, that TNF-α 
induces not only TLR2 mRNA, but also the protein. 
These findings are in agreement with the reported effects of TNF-α on TLR2 expression by 
other non-immune cell types, including HUVEC cells, human airway epithelial cells, and 
microglia cells. Recently, Wara-aswapati and colleagues142 observed that P.gingivalis 
infection induces TLR2 expression in gingival fibroblasts and that this might be a secondary 
effect mediated by an early autocrine action of TNF-α. In this same study, anti-TNF-α 
neutralizing antibodies were found to suppress the effects of P.gingivalis on TLR2 mRNA 
I
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expression. Accordingly, these researchers propose that the up-regulation of TLR2 by 
P.gingivalis in gingival fibroblasts is at least partially dependent on TNF-α.142 In light of 
findings on the role of TLRs in the pathogenesis of various autoimmune, chronic 
inflammatory and infectious diseases,143,144 blocking TLR2 signaling may help reduce the 
levels of cytokines that promote destruction of periodontal tissue.145,146  
Signaling pathways involved in up-regulation of TLR2 by TNF-α in 
gingival fibroblasts 
Since the microarray analysis revealed that TNF-α up-regulates genes whose products are 
components of signaling pathways involved in inflammatory responses, including the JNK 
(MAP3K8), NF-ĸB (IKBKE), janus kinase 2/signal transducer and activator of transcription 
1(JAK2/STAT1), as well as the prostaglandin signaling pathway, the possible role of these 
pathways in regulation of TLR2 expression induced by TNF-α was explored next. 
MAP3K8, a serine-threonine protein kinase member of the MAP3K family, initiates the 
stress-signaling JNK pathway.147 We found that inhibition of this pathway attenuates the 
induction of both TLR2 mRNA and protein expression by TNF-α. The JNK pathway also 
appears to play a role in the chronic inflammatory disease rheumatoid arthritis. For example, 
in a mouse model of arthritis, pharmacological inhibition of this pathway prevented the onset 
of arthritis and abrogated joint swelling.148 These findings together with our own indicate that 
inhibitors of JNK might disrupt TNF-α-induced signal transduction and thereby decrease 
expression of TLR2, providing a possible therapeutic target for controlling inflammation. 
Activation of the gene encoding IKBKE leads to dissociation of NF-ĸB from its inhibitor IĸB 
kinase. Inhibition of NF-ĸB decreased TLR2 expression in gingival fibroblasts. The 
contribution of NF-ĸB to regulation of TLR2 expression is also indicated by the finding that 
inhibitors of this factor diminish TNF-alpha-induced TLR2 expression in mouse microglia 
cells and astrocytes.149,150 Thus, a potent inhibitor of this pathway might be a valuable tool for 
treatment of diseases involving chronic inflammation.149,150  
An additional gene upregulated by TNF-α in our cells was the transcription factor STAT1, 
which is involved in the TLR signaling pathway.151 Recently, one report demonstrated that 
STAT1 undergoes rapid phosphorylation in response to stimulation by TLR ligands, 
suggesting that this transcription factor plays a crucial role in TLR-induced inflammation.152 
We found here, however, that inhibition of the JAK2/STAT1 signaling pathway did not 
reduce induction of TLR2 mRNA nor protein by TNF-α, indicating that this pathway may not 
be involved. 
The prostaglandin15d-PGJ2, a known anti-inflammatory mediator,153 is activated by the 
release of arachidonic acid via PLA2,154 and in turn activates the transcription factor 
peroxisome proliferator-activated receptor gamma (PPAR-γ).153,154 Since the gene for cPLA2, 
was also up-regulated by TNF-α in gingival fibroblasts, we further explored the role of 15d-
PGJ2 in TNF-α-induced TLR2 expression and showed that this prostaglandin inhibits this 
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induction. In immune cells resident in the brain, LPS-induced expression of TLR2 is down-
regulated by 15d-PGJ2.155 Furthermore, in a murine model of periodontitis 15d-PGJ2 exerted 
immuno-modulatory effects, attenuating bone resorption and inflammatory responses.156 
These studies together with our own suggest that 15d-PGJ2 may play a part in the resolution 
of inflammation.155,156  
Even though cell cultures are commonly used as models for investigating complex diseases 
such as periodontitis, such systems lack important features present in vivo. Therefore, in the 
two next studies we explored the gene expression profile of gingival tissue from both patients 
with periodontitis and periodontally healthy subjects. 
STUDY II  
In Study II, gene expression in periodontitis-affected and healthy tissues from the same 
individuals was examined. Both histological and immunohistochemical analysis revealed 
more extensive inflammation in diseased gingival tissue. Moreover, cluster analysis 
demonstrated that the degree of inflammation, rather than the specific individual involved 
appeared to influence the clustering, indicating a characteristic gene expression profile for 
periodontitis. Furthermore, we identified two novel genes associated with periodontitis, 
namely IRF4 and CCL18. 
By comparing diseased and healthy gingival tissues from the same patient (n=10), we 
minimized the effect of individual variation. Infiltration by inflammatory cells and the 
numbers of CD3-positive cells, determined by histological and immunohistochemical 
analysis, were higher in the periodontitis-affected gingival tissue. Similarly, RNA-seq 
revealed higher expression of pro-inflammatory markers in most of the periodontitis-affected 
biopsies. These findings support the conclusion that periodontitis is characterized by an 
inflammatory burden.157,158  
RNA sequencing analysis 
The RNA-seq data was initially analyzed using cluster analysis, revealing that the majority of 
the healthy gingival biopsies clustered together whereas most of the periodontitis-affected 
tissues grouped together. However, 3 of the 10 patients deviated from the typical clustering 
pattern, possibly due to the degree of inflammation in their gingival tissue or other systemic 
conditions. 
RNA-seq comparison of genes expressed in periodontitis-affected and healthy gingival tissue 
revealed that those expressed solely in the periodontitis-affected tissue were related to 
categories/pathways indicative of inflammation, including cytokines, chemokines, and the 
JAK/STAT signaling pathways. In the healthy gingival tissues, on the other hand, the genes 
expressed were indicative of non-inflammatory pathways. These findings are consistent with 
the elevated increased inflammatory response observed in the periodontitis-affected gingival 
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tissue histologically, as well as the demonstration by our microarray analysis in Study I that  
TNF-α induces inflammatory genes in gingival fibroblasts.127,159 Our results are also in 
agreement with earlier demonstrations that immune and inflammatory pathways dominate the 
patterns of gene expression connected with the pathogenesis of periodontitis and that 
cytokines and inflammatory mediators play critical roles in the preservation of tissue 
homeostasis.45,121,158 
Differential gene expression analysis 
One of the essential reasons for analysing gene expression data is to identify genes that are 
expressed differentially in two different samples. Among the top 50 genes revealed by 
differential gene expression analysis to be most strongly up-regulated in periodontitis were 
the two novel genes IRF4 and CCL18, with overexpression of the corresponding proteins as 
well, confirming their possible involvement in the pathogenesis of periodontitis.  
The transcription factor IRF4 has been reported to regulate expression of the pro-
inflammatory cytokines IL-17 and IL-21,165,166 the levels of both of which are elevated in 
periodontitis.45 Furthermore, this transcription factor appears to be involved in other chronic 
inflammatory diseases as well, including T-cell-dependent chronic inflammatory diseases 
such as inflammatory bowel disease (IBD), with a correlation between the levels of IRF4 
mRNA and production of cytokines, including IL-6 and IL-17, in inflamed colon from 
patients with IBD.160 Thus, IRF4 may be involved in the regulation of chronic mucosal 
inflammation.160 With respect to rheumatoid arthritis, one recent article reported that binding 
sites for the transcription factor IRF4 are over-represented in the promoters of genes 
associated with susceptibility to this disease.161  
The level of chemokine CCL18, expressed by macrophages, monocytes and dendritic cells, is 
elevated in the synovial tissue of rheumatoid arthritis patients.162 Furthermore, blockage of 
CCL18 expression by anti-TNF-α-antibodies suggests that this chemokine may represent an 
additional potential target for anti-TNF-α therapy of patients with rheumatoid arthritis.163,164  
However, the potential role of the transcription factor IRF4 and chemokine CCL18 in the 
pathology and progression of periodontitis requires more detailed investigation. 
Although our study population was small, we believe using periodontitis-affected and healthy 
gingival tissue from the same patient minimizes individual variation that in some cases may 
mask the expression of genes specific for this disease. However, the characteristics of the 
healthy sites in such patients may not be identical to those in periodontally healthy subjects, 
which could hamper the identification of susceptibility genes for periodontitis. Moreover, 
Study II should be considered a pilot study, in which a relatively small group was employed 
to evaluate the applicability of the RNA-seq technique, which was relatively new at the time, 
along with proper handling of the gingival tissue samples. 
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STUDY III  
Study III on a larger cohort of patients with periodontitis (n=62) and healthy control subjects 
(n=62) is, to our knowledge, the first to utilize RNA-seq for transcriptome analysis in this 
context. With such a large sample population it is easier to detect differentially expressed 
genes, since a higher number of replicates provides significantly better detection power.114  
As in Study II, we initially evaluated the degree of infiltration by inflammatory cells into the 
gingival tissue of all subjects for subsequent comparison with the gene expression data. As 
expected, H&E staining demonstrated that the patients with periodontitis generally showed 
more severe inflammation. Macrophages, key components of the innate immune, are present 
in higher numbers in active periodontal lesions than inactive sites.165 B cells represent 
approximately 18% of the cells in periodontitis lesions166 and appear to contribute to the 
degradation of connective tissue structures in periodontitis, as well as in other chronic 
inflammatory diseases.167,168 Utilizing immunohistochemistry, we found pronounced 
expression of CD20 (B cells) and CD68 (macrophages) in gingival connective tissue from 
patients with periodontitis, compared to healthy gingival tissues.  
Transcriptome analysis 
As a first step, multivariate analysis was performed to examine the general variance of gene 
expression in the data set. The largest variation was associated with the degree of 
inflammation, and the second largest variation was associated with the origin of the samples, 
i.e., from patients with periodontitis or healthy control subjects. These findings indicate that 
even though the degree of inflammation is higher in those with periodontitis, certain patterns 
of gene expression distinguish periodontitis from healthy tissue independently of the degree 
of inflammation. Additional multivariate analysis revealed that the two genes whose 
expression was most distinct in the case of periodontitis and might thus serve as biomarkers 
for this disease were those encoding MUC4 and MMP7. 
Differentially expressed genes in periodontitis 
The subsequent analysis of differentially expressed genes in Study III showed 665 genes to 
be up-regulated and 633 down-regulated in periodontitis in comparison to healthy control 
tissue. Furthermore, the results of enrichment analyses were consistent with previous studies, 
indicating up-regulation of immune and inflammatory responses, as well as processes related 
to apoptosis.121,125,169,170 Up-regulation of the immune response was consistent with the 
histological staining indicating more pronounced inflammation in gingival tissue from 
patients with periodontitis. Among the down-regulated genes, the enriched biological 
processes included organization of collagen fibrils and the extracellular matrix as well as 
bone development, which could reflect the disrupted tissue homeostasis characteristic of 
periodontitis. 
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Differential expression analysis identified MUC4 and MMP7 as the two genes most 
pronounced in connection with periodontitis and immunohistochemical analysis showed that 
both the MUC4 and MMP7 proteins were also expressed at significantly higher levels in 
gingiva from patients with periodontitis than in healthy controls. This over-expression of 
MUC4 and MMP7 at both the mRNA and protein level makes them potential biomarkers for 
periodontitis.  
MUC glycoproteins lining the apical surface of epithelial cells have been detected in saliva 
and are thought to contribute to the clearance of oral pathogens, by preventing them from 
reaching the cell surface.171,172 Moreover, the level of MUC4 in human gingival tissue 
increases upon induction of experimental gingivitis,170 and an aberrant overexpression of 
MUC4 has been reported in malignant epithelial cells. Thus, MUC4 has been proposed to 
represent an attractive target for the development of antibodies, vaccines and therapeutic 
inhibitors.173  
The gene up-regulated to the second greatest extent in periodontitis encodes MMP7, which 
belongs to the MMP family of enzymes that degrade components of the extracellular matrix 
and basement membrane.174-176 MMP7 is expressed constitutively in the epithelium, most 
notably in the salivary glands. Although, the overall role of MMP7 in periodontal disease 
remains unclear,69 we show here for the first time that MMP7 is overexpressed in gingival 
connective tissue from patients with periodontitis. The role of other MMPs in periodontitis is 
indicated by the elevated levels of MMP2, MMP8, and MMP9 proteins in gingival tissues, 
saliva, and GCF from patients with periodontitis.77,177-181 
Because of certain limitations, the gene expression data presented here must be subjected to 
further verification in order to understand its precise biological significance. For instance, 
although differential expression analysis identified genes that were up- or down-regulated in 
the gingival tissue, this analysis does not take into consideration possible interactions 
between products of the differentially expressed genes and additional investigations of such 
interactions should further enhance the understanding of their specific functions. Moreover, 
gingival biopsies are rather heterogeneous, containing a variety of cell types, including 
resident cells such as epithelial cells and fibroblasts, as well as infiltrating cells. This 
complicates interpretation of the transcriptome analysis, which originates from a mix of these 
cell types, the relative proportions of which may vary in different biopsies. One way to 
circumvent this limitation is to use techniques such as the novel RNA-seq approach, with 
which the gene expression in each individual cell in a tissue section can be investigated 
simultaneously. 
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STUDY I 
 In human gingival fibroblasts the cytokine TNF-α up-regulated the expression of a wide 
range of genes, as well as activating several signaling pathways involved in immune and 
inflammatory responses. 
 Induction of TLR2 expression at both the mRNA and protein levels by TNF-α in gingival 
fibroblasts, involved the JNK and NF-ĸB signaling pathways and was attenuated by the 
anti-inflammatory prostaglandin 15d-PGJ2. 
STUDY II 
 The degree of inflammation was more prononced in periodontitis-affected than healthy 
gingival tissue from the same patient. 
 The pattern of transcriptome in periodontitis-affected tissues was similiar in different 
individuals, indicating a characteristic gene expression profile for periodontitis. 
 The two novel genes, IRF4 and CCL18 were overexpressed in periodontitis-affected 
tissue, both at the mRNA and protein levels. 
STUDY III 
 Specific B cell (CD20) and macrophage markers (CD68) were detected at higher levels in 
gingival connective tissue from patients with periodontitis than from healthy control 
subjects. 
 The largest variation within the study population was associated with the degree of 
inflammation, and the second largest variation with the origin of the biopsies (i.e. from 
patients or healthy controls).  
 MUC4 and MMP7 were overexpressed in periodontitis, both at the mRNA and protein 
levels, and accounted for the largest difference between periodontitis tissue and healthy 
tissues. 
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ur present characterization of the global transcriptome of periodontitis should 
provide valuable insights into the molecular mechanism(s) underlying the 
pathogenesis and progression of this disease. However, these data do not provide 
definitive evidence concerning whether a particular gene is involved in the process, but rather 
identify a broad consortium of genes and pathways that are differentially expressed in the 
disease and thereby likely to be involved.  
In future studies several factors should be considered. First, the majority of our observations 
concern the transcriptome and do not necessarily reflect effects on individual functional 
proteins, the levels of which need to be determined. This can be done not only in the gingival 
tissue but also in human saliva and gingival fluid. At the same time, it must be emphasized 
that since periodontitis is a complex inflammatory disease involving multifactorial factors 
and causes it is unlikely that a single, definitive biomarker can be identified. It is more 
likely that a combination of biomarkers that together can differentiate between the healthy 
and disease state will in the future help design individual medical interventions, as well as 
predict treatment outcome. Another important approach involves the use of transgenic 
animal models, perhaps involving Knockout of genes found to be of interest here. Finally, 
more detailed in vitro studies on cultures of gingival and epithelial cells, both of which are 
involved in the inflammatory response against periodontal pathogens in periodontitis, could 
provide unique new insights.  
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a b s t r a c t
Periodontitis is a chronic inﬂammatory disease characterized by a host inﬂammatory response against
bacteria that leads to destruction of the supporting structures of the teeth. Bacterial components of
pathogens in the periodontal pocket are recognized by toll-like receptors (TLRs) that trigger an inﬂamma-
tory response. In this study, we investigated the effects of the pro-inﬂammatory cytokine tumor necrosis
factor a (TNFa) on TLR2 expression in human gingival ﬁbroblasts. In addition, we examined the signaling
pathways involved in the regulation of TNFa-induced TLR2 expression. Our results showed that TNFa
increased TLR2 mRNA and protein expression. Microarray analysis and the inhibition of speciﬁc signaling
pathways demonstrated that c-Jun N-terminal kinases (JNK) and nuclear factor kappa B (NF-jB) were
involved in the regulation of TNFa-induced TLR2 expression in gingival ﬁbroblasts. Furthermore, the
prostaglandin E2 (PGE2) regulatory enzyme cytosolic phospholipase A2 (cPLA2) and the anti-inﬂammatory
prostaglandin 15-deoxy-D12,14-prostaglandin J2 (15d-PGJ2), were found to regulate TLR2 mRNA expres-
sion stimulated by TNFa. Our ﬁndings suggest that these pathways and mediators, through the regulation
of TLR2 expression in gingival ﬁbroblasts, may be involved in the pathogenesis of periodontitis. The study
provides new insights into the molecular mechanisms underlying the regulation of TLR2, implicated in
the chronic inﬂammatory disease periodontitis.
 2011 Elsevier Ltd. All rights reserved.
1. Introduction
Periodontitis is a chronic inﬂammatory disease that is initiated
by the formation of a microbial bioﬁlm in the periodontium, which
subsequently triggers an inﬂammatory response. The host response
includes the release of pro-inﬂammatory cytokines, chemokines,
prostaglandins andproteolytic enzymes,which collectively contrib-
ute to tissue and bone destruction, characterizing periodontitis [1].
The bioﬁlm associated with periodontitis includes pathogens of
the red complex: Porphyromonas gingivalis (P. gingivalis), Tannerella
forsythia and Treponema denticola [1]. The pathogen-associated
molecular patterns of these gram-negative bacteria are recognized
by a family of pattern-recognition receptors in the innate immune
system, known as toll-like receptors (TLRs) [2,3]. To date, at least
11 members of the TLR family have been identiﬁed in humans [4].
These receptors are predominantly expressed on the surface of
numerous cells of the innate immune system, including neutrophils,
monocytes and dendritic cells. TLRs orchestrate a rapid innate im-
mune response against invading pathogens [2–4].
TLR activation, with the exception of TLR3, induces the interac-
tion between toll/interleukin-1 receptor domain-containing pro-
tein and the adaptor protein myeloid differentiation primary
response gene (MyD88). MyD88 recruits protein kinase interleu-
kin-1 receptor-associated kinase to induce the mitogen-activated
protein kinase kinase kinase (MAP3K). MAP3K in turn activates
the mitogen-activated protein kinases (MAPKs), c-Jun N-terminal
kinases (JNK) and p38 as well as the transcription factor nuclear
factor-kappa B (NF-jB) [5]. Induction of NF-jB activity contributes
to the secretion of various key inﬂammatory mediators of chronic
inﬂammatory conditions, including tumor necrosis factor a (TNFa),
interleukin-1b (IL-1b) and prostaglandin E2 (PGE2) [6,7]. In the con-
text of TNFa, increased levels of TNFa in synovial samples have
shown to be associated with the chronic inﬂammatory disease,
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rheumatoid arthritis [8]. With regard to periodontitis, enhanced le-
vel of TNFa has been demonstrated in serum as well as in gingival
crevicular ﬂuid of patients with chronic periodontitis [9,10].
Accordingly, anti-TNFa therapy has been used as a successful
treatment for rheumatoid arthritis and has also been reported to
inhibit inﬂammation and decrease bone loss in experimental peri-
odontitis [11,12].
In addition to TLRs beneﬁcial role in the host immune response,
stimulation of TLR signaling, mainly via TLR2 and TLR4, may also
contribute to the development of a number of diseases that are pro-
moted by chronic inﬂammatory processes. For example, TLR2 has
been implicated in Systemic Lupus Erythematosus (SLE), diabetes
and Alzheimer’s disease [13,14]. Furthermore, the administration
of TLR2 and TLR4 ligands to mice leads to a signiﬁcant acceleration
in atherosclerosis [15,16]. In the context of periodontitis, studies
have reported elevated levels of TLR2 and TLR4 in gingival tissues
frompatientswith chronic periodontitis, compared to periodontally
healthy controls [17]. Lappin et al. [18] demonstrated that the TLR2
and TLR4 agonists, Pam3-Cys-Ser-Lys4 (Pam3CSK4) and lipopolysac-
charide (LPS) are elevated in saliva from patients with periodontal
disease. In addition, it has been shown that gingival ﬁbroblasts,
the major cell type of the periodontal connective tissue, express
TLR2 and TLR4 [19,20]. Furthermore, a study by Gutierrez-Venegas
et al. [21] demonstrated that gingival ﬁbroblasts treated with the
speciﬁc TLR2 ligand; LPS from periodontitis associated bacteria P.
gingivalis, promoted the expression of cyclooxygenase-2 (COX-2)
and PGE2 synthesis.
Although it is known that TLR2 is expressed in gingival tissues
from patients with periodontitis, and that the expression of the
receptor increases in chronic inﬂammation [22], the signaling
pathways involved in the induction of TLR2 remains unclear. The
aim of this study was to investigate the expression and regulation
of TLR2 in human gingival ﬁbroblasts stimulated with the pro-
inﬂammatory cytokine TNFa. Additionally, a global gene expres-
sion proﬁle utilizing microarray technology, was used to explore
the involvement of different signal transduction pathways in the
regulation of TNFa-induced TLR2 expression in gingival ﬁbroblasts.
2. Materials and methods
2.1. Cell cultures of gingival ﬁbroblasts
Human gingival ﬁbroblast cultures were established from gingi-
val biopsies obtained from ﬁve healthy subjects aged 3–12 years
with no clinical signs of periodontal disease. The Regional Ethics
Board in Stockholm approved the collection of biopsies. Minced
pieces of gingival tissue were explanted to 25 cm2 Falcon tissue
culture ﬂasks containing 5 ml of DMEM supplemented with peni-
cillin (50 units/ml), streptomycin (50 lg/ml) and 5% FCS (Invitro-
gen Life Technologies, Scotland, UK). Gingival ﬁbroblasts were
obtained by trypsinization of the primary cell outgrowth and, were
grown at 37 C with 5% CO2 and routinely passaged using 0.025%
trypsin in PBS containing 0.02% EDTA. Human gingival ﬁbroblasts
from passage level 4 to 10 were used in this study. The cells were
seeded in 60-mm Petri dishes in DMEM supplemented with 5% FCS
and cultured for 24 h at 37 C. Thereafter, the cell layers were
rinsed with serum-free DMEM followed by the addition of 3.0 ml
DMEM containing the pro-inﬂammatory cytokine TNFa (20 ng/
ml) (R&D Systems, Minneapolis, MN, USA) in the absence or pres-
ence of different test substances including SP 600125 (10 lM) (SP;
Sigma–Aldrich), RO 106-9920 (4 lM) (RO; Tocris Bioscience,
Bristol, UK), Tyrphostin AG 490 (8 lM) (AG-490; R&D Systems),
4-bromophenacyl bromide (5 lM) (BPB; Sigma–Aldrich), celecoxib
(10 lM) (Cayman Chemical, Ann Arbor, MI, USA) exogenous PGE2
(5 lM) (Sigma–Aldrich) or 15-deoxy-D12,14-prostaglandin J2
(5 lM) (15d-PGJ2; Cayman). Control cells were treated with culture
medium only. After an incubation period the cell monolayer was
washed twice with PBS and cells were collected for oligonucleotide
microarray, reverse transcriptase-PCR (RT-PCR) or ﬂow cytometric
analysis.
2.2. RNA extraction
The cells were treated with TNFa (20 ng/ml) for 1, 3 or 6 h for
microarray analysis and with TNFa in the presence or absence of
test substances for 6 h for RT-PCR analysis. After incubation, cells
were immediately frozen in liquid nitrogen and then stored at
70 C for subsequent isolation of total RNA. RNA was isolated
using an RNeasy Mini Kit (Qiagen, Valencia, CA, USA) and quanti-
ﬁed spectrophotometrically at 260/280 nm. The RNA quality was
assessed using the RNA 6000 Nano LabChip kit of the Bioanalyzer
system (Agilent Technologies, Palo Alto, CA, USA).
2.3. Design of microarray experiments
The experimental design of the microarray study was set up as a
time-course factorial design with the time points 1, 3 and 6 h to al-
low identiﬁcation of TNFa-induced gene expression changes over
time [24]. Each sample was measured four times in different com-
parisons, and the same design was repeated for ﬁbroblasts isolated
from three different subjects. For further details on the design of
the microarray experiments, see Båge et al. [23].
2.4. Labeling and cDNA synthesis for microarray analysis
The synthesis and labeling of cDNAwas performed as previously
described by Lindberg et al. [25]. Brieﬂy, Superscript III (Invitrogen)
Fig. 1. TNFa increases TLR2 mRNA and protein expression in gingival ﬁbroblasts.
(A) The cells were stimulated with medium control or TNFa (20 ng/ml) for 6 h and
the mRNA expression of TLR2 and GAPDH was analyzed by RT-PCR. The graph
shows semi-quantiﬁcation of TLR2 mRNA in relation to GAPDH, expressed as
relative to control. Results are presented as mean ± SD and the asterisk () indicates
a signiﬁcant difference from control (ctrl) cells (p < 0.05). (B) The protein expression
of TLR2 in cells stimulated with TNFa for 24 h and analyzed by ﬂow cytometry
using TLR2 speciﬁc antibody. All analyses were performed in triplicates and the
results shown are representative of three separate experiments.
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and randomhexamerprimers (Operon,AlamedaCA,USA)wereused
for cDNA synthesizing. The reaction was terminated and RNA was
hydrolyzed with EDTA and HCl. The pH was restored using NaOH
and cDNA puriﬁcation was performed using the MinElute Reaction
CleanupKit (Qiagen). Forwashingandelutionof the cDNA,80%EtOH
and NaHCO3 pH 9 was used instead of supplied buffers due to the
presence of Tris, which would affect the subsequent labeling reac-
tion. Labeling was performed using the ﬂuorescent cyanine (Cy)
dyes, Cy3 and Cy5monoreactive esters (Amersham-Biosciences, Lit-
tle Chalfont, Bucks, UK). The labelingmixturewas puriﬁed using the
MinElute Reaction Cleanup Kit (Qiagen) according to the manufac-
turer’s protocol. Conﬁrmation of labeling success andmeasurement
of the ﬂuorophore concentrations was performed using a Nanodrop
instrument (Nanodrop Technologies, Wilmington, DE, USA). The
ﬂuorophore concentrations of the labeling reactions were used to
balance the sample volumes.
2.5. Oligonucleotide microarray
Oligonucleotide microarrays used in this study were printed at
the KTH microarray core facility [26]. The 70-mer oligos originated
from version 3.03 of Operons Human Genome Oligo Set, and the
microarray contained 35344 features representing 28948 Entrez
Gene ID:s [27] of which 17972 were unique. For additional infor-
mation regarding the oligonucleotide microarray, such as the oligo
set and the array manufacturing, see Båge et al. [23].
2.6. Hybridization
The microarrays were prehybridized with a bovine serum albu-
min-based buffer for 30 min, in a 42 C water bath as previously
described [25]. After washing, the corresponding Cy3 and
Cy5-labeled samples were pooled and hybridization buffer was
added to the mixture. Lifter slips (Erie Scientiﬁc Company, Shelton,
CT, USA) were used to contain the hybridization mixture on the ar-
ray during hybridization. The arrays were hybridized overnight at
42 C in a water bath, and after subsequent washing the arrays
were immediately scanned.
2.7. Scanning and image processing
Scanning was performed on an Agilent G2565BA scanner
(Agilent Technologies, Palo Alto, CA, USA) using a scanner resolu-
tion of 10 lm, as previously described [25]. The software GenePix
5.1.0.0 (Axon Instruments, Foster City, CA, USA) was used to extract
the raw signals from the TIFF images and to assign each spot an ID.
2.8. Statistical methods and low-level analysis of microarray data
The data was analyzed as previously described [23], using dif-
ferent packages in the software R [28]. All packages, except the
KTH package [27] were available in the Bioconductor open source
software project for analysis of genomic data [29]. For low-level
analysis, the raw data from GenePix was read into the software
R, spots were ﬁltered for abnormal physical properties and slides
were normalized using a print tip Lowess normalization [25,30].
For estimation ofM-value and variance for each gene, a linear mod-
el in the Bioconductor package LIMMA (Linear models for micro-
array data) was set up. The M-value was the log2 of the fold
change, for example gene expression of TNFa treated cells/gene
expression of control cells. The microarray data set has been
deposited at the Gene Expression Omnibus (National Center for
Table 1
List of top 10 regulated biological signaling pathways in each time comparison due to TNFa stimulation in gingival ﬁbroblasts.
Time
comparison
Signaling pathway Total number of genes
in the pathway
Number of regulated
genes in the pathway
p Valuea
1 h TNF-alpha/NF-jB signaling pathway 190 21 3.1  1015
Apoptosis 82 12 1.0  1010
Toll-like receptor signaling pathway-mir 138 13 4.4  109
Toll-like receptor signaling pathway 103 10 2.0  107
Adipogenesis 133 11 2.6  107
Id signaling pathway 51 7 1.3  106
EBV LMP1 signaling 22 5 3.4  106
Selenium 86 8 4.7  106
Cytokines and inﬂammatory response
(BioCarta)
23 5 4.3  106
DNA damage response
(only ATM dependent)
92 8 7.7  106
1–3 h Apoptosis 82 22 1.4  1022
Toll-like receptor signaling pathway-mir 138 25 6.5  1021
Type II interferon signaling (IFNG) 51 15 1.7  1016
Toll-like receptor signaling pathway 103 18 3.8  1015
TNF-alpha/ NF-jB signaling pathway 190 22 2.5  1014
IL-2 signaling pathway 77 15 1.4  1013
IL-4 signaling pathway 63 13 2.7  1012
Adipogenesis 133 17 4.3  1012
EGFR1 signaling pathway 178 19 6.2  1012
IL-7 signaling pathway 44 11 1.4  1011
3–6 h Type II interferon signaling (IFNG) 51 14 3.6  1017
Toll-like receptor signaling pathway 103 9 6.5  107
Adipogenesis 133 10 6.4  107
Toll-like receptor signaling pathway-mir 138 10 8.9  107
IL-2 signaling pathway 77 7 8.9  106
Androgen receptor signaling pathway 115 8 1.5  105
IL-7 signaling pathway 44 5 6.0  105
EGFR1 signaling pathway 178 9 5.6  105
Kit receptor signaling pathway 67 6 4.3  105
Apoptosis 82 6 1.0  105
ap Value indicates the signiﬁcance of the enrichment, p < 0.05.
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Biotechnology Information) with Accession No. GSE13903 [31].
Subsequently, differentially expressed genes were identiﬁed in
the different contrasts of interest using a moderated t-test [32]. A
false discovery rate algorithm was then applied to the calculated
p values to correct for multiple testing [33]. Thereafter, differen-
tially expressed genes were deﬁned as genes with a q value
<0.05 (the false discovery rate analog of a p value), meaning that
the proportion of false positives among the differentially expressed
genes was 0.05. Enrichment analysis of the data was then per-
formed using the WikiPathways database through WEB-based
Gene Set Analysis Toolkit V2 (WebGestalt) [34], to discover which
intracellular pathways were regulated among the differentially
expressed genes at the different time comparisons of TNFa
treatment.
2.9. RT-PCR
For the reverse transcription reaction, Superscript II (Invitrogen)
was used with 1.0 lg total RNA in a total reaction volume of 20 ll.
PCR ampliﬁcations were performed using 5.0 ll cDNA and
AmpliTaq Gold DNA polymerase (Invitrogen) to a ﬁnal reaction vol-
ume of 50 ll, with speciﬁc commercial primer pairs for TLR2
(Invivogen, San Diego, CA, USA). The samples were ampliﬁed
(GeneAmp PCR 9600; Applied Biosystems) for TLR2 by an initial
denaturation for 2 min at 95 C, followed by 35 cycles of ampliﬁca-
tion (95 C for 30 s, 60 C for 30 s and 72 C for 2 min) and an addi-
tional extension step for 5 min at 72 C. GAPDH (R&D Systems) was
used as control and the reactions were performed according to the
manufacturer’s recommendation. For each experiment, PCR ampli-
ﬁcations were also performed without cDNA to obtain negative
controls. Ten microliters of each PCR reaction product was run
on 2% agarose gels containing Gelred (Bio-nuclear Scandinavia,
Stockholm, Sweden), together with 1 kb DNA-ladder standard
(Invitrogen). The product sizes were 657 bp for TLR2 and 576 bp
for GAPDH. The RT-PCR products were quantiﬁed using the molec-
ular imager Chemidoc XRS system (Bio-Rad, Hercules, CA, USA) by
measuring the volume intensity of the bands.
2.10. Flow cytometric analysis
Gingival ﬁbroblasts were seeded into 60-mm Petri dishes and
grown as described above. After treatment with TNFa (20 ng/ml)
for 24 h, the cells were collected by trypsinization and washed
three times with PBS. Thereafter, the cells were stained with
anti-human monoclonal TLR2 antibody (R&D systems) followed
by secondary goat anti-mouse Fluorescein Isothiocyanate-labeled
antibody (DakoCytomation, Glostrup, Denmark). After washing
with PBS buffer, the gingival ﬁbroblasts were resuspended in PBS
Table 2
Differentially expressed genes within the TLR signaling pathway.
Time
comparison
Symbol Gene name M-value a Fold change p Valueb
1 h TNF Tumor necrosis factor (TNF superfamily, member 2) 0.79 1.7 1.4  109
IFNAR2 Interferon (alpha, beta and omega) receptor 2 0.97 2.0 3.8  1010
IL6 Interleukin 6 (interferon, beta 2) 2.86 7.3 4.1  1019
PIK3R1 Phosphoinositide-3-kinase, regulatory subunit 1 (alpha) 0.28 1.2 4.6  103
MAP3K8 Mitogen-activated protein kinase kinase kinase 8 0.60 1.5 7.4  108
NFKBIA Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 3.68 12.8 2.1  1021
IL8 Interleukin 8 4.07 16.8 1.5  1010
NFKB1 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 0.54 1.5 6.2  105
TICAM1 Toll-like receptor adaptor molecule 1 0.29 1.2 1.2  103
NFKB2 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) 0.51 1.4 9.0  105
1–3 h TNF Tumor necrosis factor (TNF superfamily, member 2) 0.46 0.7 2.1  103
IFNAR2 Interferon (alpha, beta and omega) receptor 2 1.25 2.4 5.9  1010
TICAM2 Toll-like receptor adaptor molecule 2 0.36 1.3 1.6  103
PIK3R1 Phosphoinositide-3-kinase, regulatory subunit 1 (alpha) 0.39 1.3 4.4  103
MAP2K1 Mitogen-activated protein kinase kinase 1 0.31 1.2 0.05
IFNAR1 Interferon (alpha, beta and omega) receptor 1 0.46 1.4 3.0  104
CD40 CD40 molecule, TNF receptor superfamily member 5 0.40 1.3 3.6  103
CXCL10 Chemokine (C–X–C motif) ligand 10 2.35 5.1 3.0  104
TLR3 Toll-like receptor 3 0.40 1.3 0.01
IKBKE Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon 0.63 1.6 5.1  104
IL6 Interleukin 6 (interferon, beta 2) 0.79 1.0 3.0  103
NFKB1 Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (p105) 1.09 2.1 2.2  108
NFKBIA Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 0.69 0.6 1.3  103
STAT1 Signal transducer and activator of transcription 1, 91 kDa 0.66 1.6 4.0  104
TRAF3 TNF receptor-associated factor 3 0.48 1.4 3.2  106
PIK3CD Phosphoinositide-3-kinase, catalytic, delta polypeptide 0.39 1.3 5.3  103
NFKB2 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) 0.78 1.7 1.0  105
RELA v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light
polypeptide gene enhancer in B-cells 3, p65 (avian)
0.47 1.4 1.6  104
3–6 h TLR2 Toll-like receptor 2 0.35 1.3 6.4  103
CXCL10 Chemokine (C–X–C motif) ligand 10 2.46 5.5 6.0  105
TLR3 Toll-like receptor 3 0.60 1.5 2.6  106
IKBKE Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon 0.49 1.4 0.01
IL6 Interleukin 6 (interferon, beta 2) 0.70 1.6 2.0  103
STAT1 Signal transducer and activator of transcription 1, 91 kDa 1.38 2.6 1.2  1010
IRF7 Interferon regulatory factor 7 1.16 2.2 5.1  107
MYD88 Myeloid differentiation primary response gene (88) 0.34 1.3 1.3  106
RELA v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa
light polypeptide gene enhancer in B-cells 3, p65 (avian)
0.38 1.3 3.4  103
aPositive M-values indicate genes upregulated by TNFa, and negative M-values indicate genes down-regulated by TNFa.
bDifferential expression is deﬁned as p < 0.05.
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and analyzed regarding cell surface expression of TLR2 in a
FACSCalibur™ ﬂow cytometer using CellQuestPro software (Becton
& Dickinson, San Jose, CA, USA). For each sample, between 10,000
and 20,000 events were acquired. The results are shown in graphs
presenting the ﬂuorescence intensity, drawn using the software R
together with the package rﬂowcyt [28,29], and by dot-plot analy-
ses using the CellQuestPro software (Becton & Dickinson).
2.11. Statistics for non-microarray analyses
All non-microarray experiments were performed in ﬁbroblasts
obtained from at least three subjects and reproducible data is
shown as the mean ± SD of triplicate analyses. Student’s t-test
(two-tailed) was used in the statistical analysis and p values less
than 0.05 were considered statistically signiﬁcant.
A
B
Fig. 2. Illustration of time-dependent cross-talk and expression of regulated genes within the TLR signaling pathway. Gingival ﬁbroblasts were cultured with or without TNFa
(20 ng/ll) for 1, 3 or 6 h and gene expression was analyzed by microarray. (A) The TLR signaling pathway according to WikiPathways [34] with the unregulated TLR7-9
removed for clarity. Genes within the TLR signaling pathway that were signiﬁcantly regulated at the different time points are highlighted in yellow (1 h), orange (1–3 h) and
red (3–6 h). (B) TNFa-stimulated time-dependent expression of the selected genes MAP3K8, IKBKE and STAT1 in comparison to TLR2 and TNFa from the TLR signaling
pathway.
410 H. Davanian et al. / Cytokine 57 (2012) 406–416
3. Results
3.1. TNFa induces TLR2 mRNA and protein expression in human
gingival ﬁbroblasts
To investigate whether the pro-inﬂammatory cytokine TNFa
could induce TLR2 mRNA and protein expression in gingival
ﬁbroblasts, cells were stimulated with TNFa (20 ng/ml). Analysis
by RT-PCR showed that TLR2 mRNA levels were elevated
(p < 0.05) by TNFa in 6 h cultures compared to control cells
(Fig. 1A). In agreement with mRNA expression, ﬂow cytometry
showed TLR2 levels to be enhanced in response to TNFa (Fig. 1B).
3.2. Gene expression analysis in TNFa-stimulated human gingival
ﬁbroblasts
TNFa was used for further gene expression analysis through
microarray analysis. We identiﬁed differentially expressed genes,
which were deﬁned as a false discovery rate <0.05, in response to
1, 3 and 6 h of TNFa stimulation. Using a time-course factorial de-
sign, we identiﬁed genes that were differentially regulated be-
tween the selected time points with optimal statistical efﬁciency
[23,24]. Complete lists of the differentially expressed genes within
this data set, at all time comparisons of TNFa treatment, can be
found in Supplementary File 1. Gene enrichment analysis was per-
formed among the differentially expressed genes, across the differ-
ent time comparisons, to identify TLR2 and TLR-related signaling
pathways in TNFa-stimulated cells. The top 10 signiﬁcantly regu-
lated signaling pathways at each time comparison of TNFa-treat-
ment are presented in Table 1. Among the regulated signaling
pathways, the TLR signaling pathway was identiﬁed at 1 h, at the
time comparisons between 1 and 3 h, as well as between 3 and
6 h of TNFa-stimulation (Table 1). For a complete list of all regu-
lated pathways at each time comparison see Supplementary File 2.
Given that the TLR signaling pathway was regulated at all time
comparisons of TNFa treatment we further investigated the differ-
entially expressed genes within this pathway. A complete list of all
differentially expressed genes within the TLR signaling pathway,
including gene symbols, gene names, M-values, fold changes and p
values are presented in Table 2. Among these differentially ex-
pressed genes, TLR2 was upregulated at the time comparisons be-
tween 3 and 6 h of TNFa-stimulation. Additional upregulated
genes at this time comparison were C–X–C motif chemokine 10
(CXCL10), TLR3, inhibitor of kappa light polypeptide gene enhancer
in B-cells, kinase epsilon (IKBKE), IL-6, signal transducer and
activator of transcription (STAT1), interferon regulatory factor 7
(IRF7),MyD88 and v-rel reticuloendotheliosis viral oncogenehomo-
log A (RELA). In total, the cross-talk within the TLR signaling path-
way included 25 genes that were signiﬁcantly regulated by TNFa
in gingival ﬁbroblasts at the different time comparisons (Fig. 2A).
The time-dependent regulationof the genes for IKBKE, STAT1aswell
as MAP3K8 in relation to TLR2 and TNFa (Fig. 2B), instigated further
studies of the involvement of the JNK,NF-jB and JAK2/STAT1 signal-
ing pathways in the regulation of TLR2 in response to TNFa.
3.3. TNFa-induced TLR2 mRNA and protein expression is regulated by
JNK and NF-jB but not by JAK2/STAT1 signaling pathway
MAP3K8 was upregulated within the TLR signaling pathway fol-
lowing 1 h of TNFa treatment, (Table 2 and Fig. 2B) and since
MAP3Ks are responsible for activation of the MAPK JNK [5], we
explored the involvement of the JNK signaling pathway in the reg-
ulation of TNFa-induced TLR2 expression. Treatment of the cells
with the speciﬁc JNK inhibitor SP (10 lM) in combination with
TNFa reduced (p < 0.05) TLR2 mRNA expression and the percent-
age of TLR2 positive cells compared to cells treated with TNFa
alone (Figs. 3A and 4B).
Furthermore, at the time comparisons between 1 and 3 h as
well as 3 and 6 h of TNFa treatment, the gene for IKBKE was upreg-
ulated (Table 2 and Fig. 2B). IKBKE is responsible for the activation
of NF-jB, therefore we investigated whether the NF-jB signaling
pathway was involved in the regulation of TNFa-induced TLR2
expression in gingival ﬁbroblasts. Cells were treated with TNFa
(20 ng/ml) in the presence or absence of the NF-jB activation
inhibitor, RO (4 lM). In the presence of the RO inhibitor, TLR2
Fig. 3. JNK and NF-jB but not the JAK2/STAT1 signaling pathway regulates
TNFa-induced TLR2 mRNA expression. Gingival ﬁbroblasts were treated for 6 h
with TNFa (20 ng/ml) in the presence or absence of (A) the JNK inhibitor SP
(10 lM), (B) the NF-jB activation inhibitor RO (4 lM) or (C) the JAK2 inhibitor AG-
490 (8 lM). The mRNA expression of TLR2 and GAPDHwas analyzed by RT-PCR. The
graphs show semi-quantiﬁcation of TLR2 in relation to GAPDH, expressed relative
to the control. Results are presented as mean ± SD and asterisks () indicate a
signiﬁcant difference from cells treated with TNFa only (p < 0.05). All analyses were
performed in triplicates and the results shown are representative of three separate
experiments.
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mRNA and the percentage of TLR2 positive cells were diminished
(p < 0.05) compared to TNFa alone (Figs. 3B and 4C).
The transcription factor STAT1, also reported tobe involved in the
TLR signaling pathway [35], increased in response to TNFa at the
time comparison between 3 and 6 h in similarity to TLR2 (Table 2
and Fig. 2B). We explored whether the JAK2/STAT1 pathway could
be involved in modulating TNFa-induced TLR2 expression. Cells
were treatedwith the speciﬁc JAK2 inhibitor AG-490 (8 lM) in com-
bination with TNFa (20 ng/ml), but the JAK2 inhibitor AG-490 did
not signiﬁcantly affect the stimulatory effect of TNFa on TLR2mRNA
Fig. 4. JNK and NF-jB but not JAK2/STAT1 signaling pathway decrease TNFa-induced TLR2 positive cells. Gingival ﬁbroblasts were treated for 24 h with (A) medium only or
TNFa (20 ng/ml) in the presence or absence of (B) the JNK inhibitor SP (10 lM), (C) the NF-jB activation inhibitor RO (4 lM) or (D) the JAK2 inhibitor AG-490 (8 lM). The
expression of TLR2 in ﬁbroblasts was determined by ﬂow cytometry. The quantiﬁed data is the percentage of TLR2 positive cells obtained from the dot plots. All results are
representative of three separate experiments.
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expression (Fig. 3C). Likewise, AG-490 did not decrease the percent-
age of TLR2 positive cells increased by TNFa (Fig. 4D).
3.4. Involvement of the prostaglandin pathway in the regulation of
TNFa-induced TLR2 expression
Gene expression analysis revealed an upregulation of MAP3K,
which is responsible for activation of the p38 signaling pathway
[5]. An activation of this signaling pathway leads to phosphoryla-
tion of the enzyme cytosolic phospholipase A2 (cPLA2) [36]. Our
microarray analysis revealed cPLA2 to be upregulated among dif-
ferentially expressed genes [23]. The involvement of the enzyme
cPLA2 in the regulation of TLR2 expression in gingival ﬁbroblasts
was investigated using the PLA2 inhibitor BPB. RT-PCR analysis re-
vealed that treatment of the cells with BPB (5 lM) decreased
(p < 0.05) TLR2 mRNA expression induced by TNFa compared to
corresponding cells treated with TNFa only (Fig. 5A).
Since PLA2 is one of the key enzymes regulating the biosynthesis
of prostaglandins [37], the involvement of PGE2 in TLR2 expression
was explored in the next series of experiments The role of COX-2,
the downstream enzyme of PLA2, which converts PLA2 products to
prostaglandins, was investigated using the COX-2 inhibitor cele-
coxib (10 lM) known to inhibit PGE2 synthesis. Results showed that
celecoxib did not signiﬁcantly affect the mRNA expression of TLR2
induced by TNFa compared to untreated cells (Fig. 5B). Similarly,
treatment of the cells with exogenous PGE2 (5 lM) did not signiﬁ-
cantly affect the expression of TLR2 induced by TNFa (Fig. 5C). In
contrast, treatment of the cells with the anti-inﬂammatory prosta-
glandin, peroxisomeproliferator-activated receptorc (PPAR-c) ago-
nist 15d-PGJ2 (5 lM) reduced (p < 0.05) TNFa-induced TLR2 mRNA
expression (Fig. 5D).
4. Discussion
The present study demonstrated that TLR2 mRNA and protein
expression was increased by the pro-inﬂammatory cytokine TNFa
in human gingival ﬁbroblasts, and that the signal transduction
pathways JNK and NF-jB, and the prostaglandin mediators cPLA2
and 15d-PGJ2 were involved in the regulation of TNFa-induced
TLR2 expression.
In the ﬁrst part of the study we showed that TNFa induced TLR2
expression in gingival ﬁbroblasts at both the mRNA and protein
levels. To our knowledge, this is the ﬁrst study investigating the ef-
fect of TNFa on the expression of TLR2 in gingival ﬁbroblasts.
TNFa-induced TLR2 expression has previously been reported in
few other non-immune cell types, including HUVEC cells, human
airway epithelial cells and microglia cells [38–40].
As a second step, we proceeded to use microarray technology to
investigate the global gene expression proﬁle over different
time points of TNFa treatment in gingival ﬁbroblasts. Here we
Fig. 5. The effect of cPLA2, 15d-PGJ2, COX-2 and exogenous PGE2 on the regulation of TNFa-induced TLR2 mRNA expression. Fibroblasts were treated with TNFa (20 ng/ml), in
the absence or presence of (A) the PLA2 inhibitor BPB (5 lM), (B) the COX-2 inhibitor celecoxib (10 lM), (C) exogenous PGE2 (5 lM) or (D) 15d-PGJ2 (5 lM). After 6 h of
incubation, TLR2 and GAPDH mRNA expression was analyzed by RT-PCR. The graphs show semi-quantiﬁcation of TLR2 mRNA in relation to GAPDH, expressed as relative to
unstimulated control (ctrl) cells. Results are presented as mean ± SD and asterisks () indicate a signiﬁcant difference from cells treated with TNFa alone (p < 0.05). All
analyses were performed in triplicates and the results shown are representative of three separate experiments.
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demonstrated that TNFa induced a broad range of immune and
inﬂammatory response genes in gingival ﬁbroblasts. Enrichment
analysis of the data set showed regulation of several signaling
pathways involved in the immune and inﬂammatory response
and that the TLR signaling pathway was among the top 10 regu-
lated pathways at all time comparisons following TNFa treatment.
To our knowledge, there are no previously published microarray
studies on TNFa-stimulated gingival ﬁbroblasts with special focus
on TLR2 regulation. However, one microarray study has been per-
formed on IL-1b stimulated gingival ﬁbroblasts, which reports en-
hanced gene expression of inﬂammatory cytokines, transcription
factors, chemokines, matrix metalloproteinases and adhesion mol-
ecules [41]. Our microarray gene expression analysis revealed sev-
eral upregulated genes within the TLR signaling pathway. Among
them, the gene for TLR2 was upregulated in response to TNFa-
stimulation, which is in agreement with the RT-PCR and protein
expression analyses. These ﬁndings are in concurrence with results
obtained in microglia cells demonstrating that stimulation with
various concentrations of TNFa augments the TLR2 mRNA expres-
sion in 6 h cultures [40].
A time-course factorial microarray study was set up in this
study to best observe the TNFa-induced gene expression changes
over time. Through this design we investigated the time dependent
expression of the genes within the TLR signaling pathway. Our
analysis showed increased expression of the gene MAP3K8 due
to TNFa stimulation. Due to the fact that MAP3K8 is responsible
for activation of the signaling pathway JNK [42], we also investi-
gated whether JNK was involved in the regulation of TNFa-induced
TLR2 expression in gingival ﬁbroblasts. Our results showed that
inhibition of JNK reduced TNFa-induced transcription of TLR2
mRNA and protein expression, suggesting the involvement of this
pathway in the regulation of TNFa-induced TLR2 expression. The
importance of the JNK pathway has also been studied in the
chronic inﬂammatory disease rheumatoid arthritis, where phar-
macologic JNK inhibition prevented the onset of arthritis and abro-
gated joint swelling in a mouse model of arthritis [43]. These data
together with our results indicate that JNK inhibitors, by interrupt-
ing TNFa-induced signal transduction and by decreasing TLR2
expression, may serve as possible therapeutic targets for control-
ling inﬂammation in the tissue.
The genes for IKBKE and TLR2 were upregulated at the same
time comparisons, between 3 and 6 h of TNFa treatment. Because
IKBKE is responsible for the dissociation of NF-jB and its inhibitor
IKB, and in addition the TLR2 promotor contains several consensus
NF-jB-binding motifs [44,45], the effect of NF-jB on the regulation
of TNFa-induced TLR2 expression was further explored. The
ﬁnding that the expression of TLR2 decreased in the presence of
NF-jB-speciﬁc inhibitor indicates that NF-jB may also be involved
in the regulation of TNFa-induced TLR2 expression in gingival
ﬁbroblasts. The contribution of NF-jB to the regulation of TLR2
has also been reported in mouse microglia cells and astrocytes
[40,46].
STAT1 was among the upregulated genes in our microarray data
set, therefore we investigated if the signaling pathway JAK2/STAT1
is involved in TLR2 expression. Our results revealed that inhibition
of JAK2 did not reduce the TNFa-induced TLR2 mRNA or protein
expression in the cells, indicating that JAK2/STAT1 may not
regulate TLR2 expression in TNFa-stimulated gingival ﬁbroblasts.
This suggestion is in agreement with studies reporting that the
JAK2/STAT1 signaling pathway is independent of the adaptor pro-
tein MyD88, which is activated by TLR2 [47,48].
Among the signiﬁcantly regulated genes within the MAPK sig-
naling pathway, the gene for cPLA2 was shown to be upregulated
following TNFa treatment. We demonstrated that inhibition of
cPLA2 down-regulated TNFa-induced TLR2 expression. Since cPLA2
is one of the key enzymes that regulates the biosynthesis of PGE2
from membrane phospholipids [37], we further elucidated the
involvement of prostaglandins, downstream metabolites of cPLA2,
in the regulation of TLR2. Therefore, experiments were performed
to study the effect of the COX-2 inhibitor celecoxib and exogenous
PGE2, as well as the anti-inﬂammatory lipid mediator 15d-PGJ2 on
the expression of TLR2 in gingival ﬁbroblasts. Neither, Celecoxib,
known to inhibit PGE2 via the COX-2 enzyme, nor exogenous
PGE2 affected the expression of TLR2, suggesting a lack of a direct
role for PGE2 in the regulation of TLR2 expression. In contrast, the
PPAR-c agonist, 15d-PGJ2 which is activated by the release of ara-
chidonic acid via PLA2 [49] and known to mediate anti-inﬂamma-
tory effects [50,51], inhibited the expression of TLR2 in gingival
ﬁbroblasts. Our results is in agreement with studies performed in
brain immune resident cells, which demonstrated that the expres-
sion of LPS-induced TLR2 expression was signiﬁcantly down-regu-
lated when treated with 15d-PGJ2 [52]. These ﬁndings suggest that
there is a possibility that 15d-PGJ2 by modulating TLR2 expression,
may partly contribute to the resolution of inﬂammation.
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Fig. 6. Schematic illustration of signaling pathways involved in TNFa-induced TLR2 expression in human gingival ﬁbroblasts.
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In conclusion, the results showed that the inﬂammatory medi-
ator TNFa increased TLR2 mRNA and protein expression in human
gingival ﬁbroblasts. The ﬁnding that TNFa, reported to be elevated
in gingival ﬂuid of patients with periodontitis [10], stimulated
TLR2 expression in gingival ﬁbroblasts suggests that TNFa may
contribute to the upregulation of the pathogen-derived TLR2
expression in gingival tissue. Furthermore, we demonstrated that
the signaling pathways JNK and NF-jB as well as the enzyme cPLA2
and the anti-inﬂammatory prostaglandin 15d-PGJ2 were involved
in the regulation of TNFa-induced TLR2 expression (illustrated in
Fig. 6). These results provide novel knowledge of the molecular
mechanisms underlying the regulation of TLR2, which is involved
in the chronic inﬂammatory disease periodontitis.
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Abstract
Periodontitis is a chronic inflammatory disease affecting the soft tissue and bone that surrounds the teeth. Despite
extensive research, distinctive genes responsible for the disease have not been identified. The objective of this study was to
elucidate transcriptome changes in periodontitis, by investigating gene expression profiles in gingival tissue obtained from
periodontitis-affected and healthy gingiva from the same patient, using RNA-sequencing. Gingival biopsies were obtained
from a disease-affected and a healthy site from each of 10 individuals diagnosed with periodontitis. Enrichment analysis
performed among uniquely expressed genes for the periodontitis-affected and healthy tissues revealed several regulated
pathways indicative of inflammation for the periodontitis-affected condition. Hierarchical clustering of the sequenced
biopsies demonstrated clustering according to the degree of inflammation, as observed histologically in the biopsies, rather
than clustering at the individual level. Among the top 50 upregulated genes in periodontitis-affected tissues, we
investigated two genes which have not previously been demonstrated to be involved in periodontitis. These included
interferon regulatory factor 4 and chemokine (C-C motif) ligand 18, which were also expressed at the protein level in
gingival biopsies from patients with periodontitis. In conclusion, this study provides a first step towards a quantitative
comprehensive insight into the transcriptome changes in periodontitis. We demonstrate for the first time site-specific local
variation in gene expression profiles of periodontitis-affected and healthy tissues obtained from patients with periodontitis,
using RNA-seq. Further, we have identified novel genes expressed in periodontitis tissues, which may constitute potential
therapeutic targets for future treatment strategies of periodontitis.
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Introduction
Periodontitis is a chronic inflammatory disease characterized by
the destruction of periodontal tissue. This common disease,
primarily initiated by periodontal pathogens, is an outcome of a
complex interaction between periodontal microorganisms and the
host inflammatory response [1]. The host response involves
proinflammatory cytokines, chemokines, prostaglandins, Toll-like
receptors and proteolytic enzymes, which have all been demon-
strated to play an important role in the pathogenesis of
periodontitis [2,3].
Studies have been performed combining in vivo and in vitro
approaches to identify genes responsible for periodontitis. To date,
there are a few published microarray studies investigating the gene
expression profile in periodontits. One microarray study reported
no significant differences in gene expression at different patholog-
ical sites in patients with chronic and aggressive periodontitis [4],
whereas Kim et al. [5] and Demmer et al. [6] showed a number of
genes that were upregulated in periodontitis compared to healthy
controls. In addition, Beikler et al. [7] demonstrated that in
periodontitis sites, the expression of immune and inflammatory
genes was down-regulated following non-surgical therapy. With
regard to in vitro studies, gene expression profiling has been
performed on gingival fibroblasts from inflamed and healthy
gingival tissues, for a limited number of inflammatory markers,
such as interleukin (IL)-1, IL-6, IL-8, tumor necrosis factor- a
(TNF-a) and CD14 [8]. Furthermore, microarray analysis has also
been performed on periodontal ligament cells and gingival
keratinocytes [9,10]. With regard to disease susceptibility at a
genomic level, one genome-wide association study (GWAS) has
been conducted in patients with aggressive periodontitis showing
an association between aggressive periodontitis and intronic single
nucleotide polymorphism rs1537415, which is located in the
glycosyltransferase gene GLT6D1 [11].
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Despite research investigating periodontitis gene expression
profiles through microarray analysis, specific genes responsible for
the disease have not yet been found. However, the recent
development of massively parallel sequencing has provided a
more comprehensive and accurate tool for gene expression
analysis through sequenced based assays of transcriptomes,
RNA-Sequencing (RNA-Seq). This method enables analysis of
the complexity of whole eukaryotic transcriptomes [12] and
studies comparing RNA-Seq and microarrays have shown that
RNA-Seq has less bias, a greater dynamic range, a lower
frequency of false positive signals and higher reproducibility
[13,14]. The aim of the present study was to investigate the
general pattern of the gene expression profile in periodontitis using
RNA-Seq. We also aimed to investigate the local variation in gene
expression at site level, comparing periodontitis-affected and
healthy gingival tissues obtained from the same patient.
Materials and Methods
Ethics Statement
The study was performed in accordance with the Declaration of
Helsinki and the current legislation in Sweden and after approval
from the Karolinska Institutet Ethical Research Board. The
Regional Ethics Board in Stockholm approved the collection of the
biopsies and informed consent was obtained from all patients.
Collection of gingival tissue samples
A total of 10 nonsmoking individuals (20 biopsies), were
included in the study. Four patients in the study group had other
types of diseases: patient 2 was undergoing investigations for the
disease sarcoidosis, patient 3 had diabetes type-2, patient 7 had a
history of osteoarthritis and patient 10 was diagnosed with asthma.
All participants were examined for periodontal disease and those
with a tooth site demonstrating a probing depth $6 mm, clinical
attachment level $5 mm and bleeding on probing were included
in the periodontitis-affected group, according to the clinical
parameters previously used as indicators of periodontitis
[15,16,17]. During flap surgery, two adjacent gingival biopsies
with identical clinical status were harvested from a periodontal
pocket affected by periodontitis. The sizes of the specimens were
approximately 262 mm, and included the connective tissue and
the epithelium. In the same subjects, two adjacent gingival biopsies
with identical clinical status and of about the same size were also
obtained from a clinically healthy gingival pocket. Clinically
healthy pockets were defined as sites with no gingival/periodontal
inflammation, no bleeding on probing, a probing depth #3.5 mm
and a clinical attachment level #3.5 mm. One of the biopsies
from each site was stored in RNA Later (Applied Biosystems,
USA) overnight at 4uC and thereafter stored at 280uC for
subsequent RNA isolation. The second biopsy from each site was
used for histological and immunohistochemical analysis.
Hematoxylin-Eosin staining
Deparaffinized serial sections of gingival tissues were formalin fixed
(4% neutral buffered formalin) and paraffin embedded. For
assessment of orientation of the epithelium and connective tissue as
well as the degree of inflammation, deparaffinized serial sections
(4 mm) were prepared and sections of each biopsy were stained with
Hematoxylin-Eosin (H&E). The degree of inflammatory cell infiltra-
tion was evaluated by three blinded observers, using a relative scale
from 0 to 3, and statistical differences between periodontitis-affected
and healthy sites were tested using the Wilcoxon signed-rank test.
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Immunohistochemical stainings in gingival tissue
For staining of the T cell marker CD3, interferon regulatory
factor 4 (IRF4) and chemokine (C-C motif) ligand 18 (CCL18),
gingival tissues were rinsed in phosphate buffered saline (PBS) with
0.1% Saponin (PBS-Saponin buffer) for 10 min. After an antigen
retrieval procedure, 10 mM Tris, 1 mM EDTA (pH 9.0) for CD3
and 0.01 M Citrate acid (pH 6.0) for IRF4 and CCL18, sections
were blocked in 1% H2O2 in PBS-Saponin for 60 min at room
temperature (RT) for CD3 and for 45 min at RT for IRF4 and
CCL18. Subsequently, tissues were rinsed in PBS-Saponin for
10 min and further treated with 3% bovine serum albumin (BSA)
diluted in PBS-Saponin for 30 min at RT. The expression of CD3,
IRF4 and CCL18 was investigated using CD3 polyclonal rabbit
antibody (1 mg/ml, PBS-Saponin) from Dako Sweden AB (Stock-
holm, Sweden), IRF4 polyclonal rabbit antibody (0.5 mg/ml, PBS-
Saponin) from Atlas antibodies (Stockholm, Sweden) and CCL18
polyclonal rabbit anti-human antibody (0.5 mg/ml, PBS-Saponin)
from Sigma-Aldrich (St. Louis, MO, USA). Normal rabbit IgG
from R&D systems (MN, USA) was used as negative control. After
incubation with primary antibody, sections were blocked with 1%
normal goat serum in PBS for 15 min. Afterwards, sections were
incubated with a biotinylated secondary antibody provided in the
Vectastain ABC-Elite Complex Kit (Vector labs, Burlingame, CA,
USA) followed by application of the Elite ABC solution for 40 min
at RT in the dark. Thereafter, sections were washed with PBS and
the peroxidase activity was visualized with 0.3% (v/v) in DAB
buffer containing 0.1% (v/v) H2O2. Finally, the slides were washed
with distilled water, dehydrated through an ethanol series (70%,
95%, 99.9%) into xylene, mounted, and photographed using a
light microscope. For CD3 stainings, the amount of positive cells
was evaluated by three blinded observers, using a relative scale
from 0 to 3, and statistical differences between periodontitis-
affected and healthy biopsies were tested using the Wilcoxon
signed-rank test.
RNA extraction
RNA was extracted from gingival biopsies using steel-bead
matrix tubes and a tabletop Fast-Prep homogenizer by two
sequential centrifugations for 20 s at speed 6.5 (Qbiogene, Irvie,
CA, USA). The RNA was purified on RNeasy Spin Columns
(Qiagen, Valencia, CA, USA), treated with DNAse H to ensure
degradation of DNA, and thereafter eluated in RNase-free water.
The average RNA yield was 15.6 mg. RNA quality was assessed
using the RNA 6000 NanoLabChip Kit of the Bioanalyzer system
from Agilent Technologies (Santa Clara, CA, USA).
Transcriptome sample preparation for sequencing
A total amount of 2–3 mg per sample was used as input material
for the RNA sample preparations. All samples had RIN values
above 8. The samples were bar-coded and prepared according to
the protocol (Cat# RS-930-1001) from the manufacturer
(Illumina, San Diego, CA, USA), as previously described by
Stranneheim et al. [18]. All sample preparation reagents were
taken from the Illumina mRNA Sample Preparation Kit or
ordered from vendors specified in the mRNA sample preparation
protocol, except for automation specific reagents: carboxylic acid
beads used for precipitation; the ethanol and tetraethylene glycol
(EtOH/TEG) and the Polyethylene Glycol and sodium chloride
(PEG/NaCl) precipitation buffers.
Clustering and sequencing
The clustering of the bar-coded samples was performed on a
cBot Cluster Generation System using an Illumina HiSeq Single
Read Cluster Generation Kit according to the manufacturer’s
instructions. The library preparations were sequenced on an
Illumina HiSeq 2000 as single-reads to 100 bp. Two sequencing
runs were performed according to the manufacturer’s instructions
where two and three lanes were used in the first sequencing and
Figure 1. H&E and CD3-stained paraffin-embedded gingival biopsies obtained from one representative patient with periodontitis.
A. H&E staining of inflammatory cells in periodontitis-affected sections. B. H&E staining of inflammatory cells in healthy gingival sections. C. Staining
of the T-cell marker CD3 in periodontitis-affected sections. D. Staining of the T-cell marker CD3 in healthy sections. E, epithelium, C, connective tissue.
doi:10.1371/journal.pone.0046440.g001
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second sequencing run, respectively (Table S1). The runs
generated a total of 402 million reads with an average of 15
million reads per sample that passed the Illumina Chastity filter;
these reads were included in the study.
Sequence analysis
All sequences were aligned to the human genome reference
hg19 with TopHat [19,20] version 1.1.4 and Samtools [21]
version 0.1.8 using TopHat standard parameters except for
parameters –solexa1.3-quals -p 8 –GTF Homo_sa-
piens.GRCh37.59.gtf. Annotations from Ensembl and RefSeq,
downloaded from University of California, Santa Cruz (UCSC)
Genome Browser, were used to assign features to genomic
positions. Sequences aligned to the human genome were assigned
to features and counted using HTSeq version 0.4.6 with
parameters -m intersection-strict -s no -t exon. The R/Biocon-
ductor package DESeq [22] was used to call differential gene
expression on read counts generated by HTSeq and to perform
hierarchical clustering of samples. All biological replicates for
healthy and periodontitis-affected had R2 (Spearman) correlation
of gene expression (read counts) above 0.92.
Functional analyses of gene lists using WebGestalt
Analyses of gene categories and pathways was performed using
the WEB-based Gene Set Analysis Toolkit v2 (WebGestalt) [23]
with parameters: Id Type: Ensembl_gene_stable_id, Ref Set:
Entrez Gene, Significance Level: p,0.05, Statistics Test: Hyper-
geometric, MTC: BH, Minimum: 2. KEGG analysis was used for
pathway enrichment analysis and the Gene ontology (GO)
Figure 2. Expression of the inflammatory mediators in periodontitis-affected and healthy tissues obtained by RNA-seq. The bars
show the expression (log2 fold change) pattern based on RNA-Seq reads of IL-1b, IL-6, IL-8, TNFa, RANTES and MCP-1.
doi:10.1371/journal.pone.0046440.g002
Figure 3. Venn diagram of mRNA transcripts. Venn diagram
showing genes that were uniquely expressed in periodontitis-affected
(1375) and healthy (511) gingival tissues. The intersection of the two
circles refers to transcripts, which are expressed in both periodontitis-
affected and healthy gingival tissues (20 236).
doi:10.1371/journal.pone.0046440.g003
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category Biological process was used for the functional annotation
analysis.
Results
Patients and gingival tissues
A total of 10 patients, six males and four females, with a mean
age of 5068, were included in the study. For each patient, a total
of four gingival biopsies of about the same size were obtained from
periodontitis-affected and healthy gingiva, with two biopsies from
each site. Bleeding status, probing depth and degree of inflam-
mation in the gingival tissues for each of the two gingival sites was
recorded (Table 1). To assess the degree of gingival inflammation
in the periodontitis-affected and healthy tissues, histological and
immunohistochemistry staining was performed using H&E and
anti-CD3 (Fig. 1). Scoring of the degree of inflammatory cell
infiltration, assessed by H&E staining, and the amount of CD3
positive cells showed significantly higher inflammation in tissue
from periodontitis-affected sites (p,0.01 for H&E and p,0.05 for
CD3; Table 1).
RNA-Sequencing
We sequenced cDNA from 10 periodontitis-affected and 10
healthy gingival tissues, with an average of 15 million reads of
100 bp in length per sample. A pairwise approach, where each
periodontitis-affected biopsy had a healthy counterpart from the
same individual, was used to eliminate the background noise of
individual-specific gene transcription, enabling acquisition of more
relevant data from the cohort. Aligning the sequence reads against
the human genome yielded a median of 68% of uniquely aligned
reads across all samples. The expression pattern, based on RNA-
Seq reads, of well-known inflammatory mediators IL-1b, IL-6, IL-
8, TNFa, Regulated upon Activation, Normal T-cell Expressed,
and Secreted (RANTES) and Monocyte Chemotactic Protein-1
(MCP-1) were analyzed in all the tissue samples. The expression
(log2 fold change) of these mediators was shown to be higher in the
majority of the periodontitis-affected gingival tissue compared to
healthy gingival tissue from the same patient (Fig. 2).
Table 2. Enriched regulated (KEGG) biological pathways among unique genes in periodontitis-affected tissues.
Pathway Total genes in pathway
Unique genes in
pathwaya Adj p valueb
Neuroactive ligand-receptor interaction 256 19 8.18e-10
Cytokine-cytokine receptor interaction 267 18 6.75e-09
Chemokine signaling pathway 190 10 0.0004
Intestinal immune network for IgA production 50 5 0.0014
Alanine, aspartate and glutamate metabolism 31 5 0.0022
Tyrosine metabolism 46 4 0.0103
Calcium signaling pathway 178 7 0.0160
Hedgehog signaling pathway 56 4 0.0161
Systemic lupus erythematosus 140 6 0.0168
Glycine, serine and threonine metabolism 31 3 0.0196
Jak-STAT signaling pathway 155 6 0.0229
Vascular smooth muscle contraction 115 5 0.0271
Arhythmogenic right ventricular cardiomyopathy (ARVC) 76 4 0.0293
aLists of uniquely expressed genes within the enriched pathways can be found in Table S1.
badj p value indicates the significance of the enrichment, (adj p,0.05).
doi:10.1371/journal.pone.0046440.t002
Table 3. Enriched regulated (KEGG) biological pathways among unique genes in healthy tissues.
Pathway Total genes in pathway Unique genes in pathwaya Adj p valueb
Neuroactive ligand-receptor interaction 256 11 8.18e-10
Glycolysis/Gluconeogenesis 62 3 6.75e-09
Calcium signaling pathway 178 4 0.0004
Gap junction 90 3 0.0014
Pyruvate metabolism 40 2 0.0022
Tryptophan metabolism 40 2 0.0103
aLists of uniquely expressed genes within the enriched pathways can be found in Table S1.
badj p value indicates the significance of the enrichment, (adj p,0.05).
doi:10.1371/journal.pone.0046440.t003
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Distribution of gene transcripts between periodontitis-
affected and healthy gingival tissues
A total of 22 122 different mRNA transcripts were expressed in
the periodontitis-affected and healthy gingival tissue samples.
Among these transcripts, 1375 were unique to the periodontitis-
affected tissue samples whereas 511 genes were uniquely
transcribed in healthy gingival tissues (Fig. 3). KEGG enrichment
analysis using WebGestalt [24] was performed among the unique
genes for the periodontitis-affected and healthy tissues which
revealed several regulated pathways indicative of inflammation for
the periodontitis-affected condition (Table 2 and Table S1). In
contrast, in the healthy gingival tissues, regulated pathways
indicated a non-inflammatory profile among the unique genes,
as demonstrated in Table 3 and Table S1.
Clustering of biopsies
Unsupervised hierarchical clustering was performed on all gene
transcripts having a median read count above a cutoff level set to
0.3 read counts per feature, to exclude expression due to spurious
transcription (Fig. 4). The gingival tissues from periodontitis-
affected sites from different patients showed a more similar gene
expression pattern than healthy gingival tissues from the same
patient. Clustering according to individual, where the paired
healthy and periodontitis-affected biopsies cluster together, was
only observed for patient 6 and 7. However, the biopsies showed a
general trend of clustering according to the degree of inflamma-
tion as assessed by H&E staining (Table 1), except for sample 7H,
sample 2H and an outlier sample 1H, which clustered separately.
There was also a trend of forming larger clusters depending on
sequence run, but paired biopsies (periodontits-affected and
healthy) from each patient were always analyzed in the same
sequence run.
Differential gene expression between periodontitis-
affected and healthy gingival tissues
Differential gene expression between periodontitis-affected and
healthy gingival tissues was analyzed using read counts for each
gene with the DeSeq package [22]. The analysis revealed a total of
453 significantly (adj p,0.01) differentially expressed genes.
Additional analyses of genes expressed in periodontitis-affected
Figure 4. Clustering dendrogram and heatmap of periodontitis-affected and healthy biopsies. Clustering of all samples was based on
gene transcripts with a median read above three times the background noise. The length of the branch between two biopsies and the colors of the
heatmap correspond to degree of similarity between the gene expression profiles. Colors can be interpreted using the scale bar. Numbers in
parentheses denote the inflammation scores of the biopsies after H&E histological evaluation.
doi:10.1371/journal.pone.0046440.g004
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gingiva, showed that 381 genes were upregulated, whereas 72
genes were shown to be down-regulated (Fig. 5, Table S2).
Gene Ontology enrichment analysis of differentially
expressed genes
Investigation of functional associations of gene expression
changes in the tissue samples was performed using WebGestalt.
Gene ontology (GO) Biological process was used for enrichment
analysis. Significant gene enrichments (p,0.05) as well as their
parent terms are demonstrated in Fig. 6. Several GO categories
were over-represented among genes differentially expressed in
periodontitis-affected versus healthy gingival tissues. The catego-
ries were mainly indicative of immune and inflammatory
responses. Further enrichment analysis regarding Molecular
function and Cellular components are provided in the supple-
mentary data (Table S3).
Top 50 upregulated genes in periodontitis-affected
gingival tissue
The top 50 significantly upregulated genes in periodontitis-
affected gingival tissue with Unigene entry are displayed in Table 4
together with Ensemble ID, gene symbol, fold change, log2 fold
Figure 6. Gene ontology (GO) analysis of differentially expressed genes. All significant (p,0.05) Biological processes (GO categories) and
their parent terms are shown. The color of each node illustrates the significance and can be interpreted using the scale bar, which displays the p
value. Each node is also marked with the number of significantly regulated genes mapped to the GO category.
doi:10.1371/journal.pone.0046440.g006
Figure 5. Volcano plot displaying differential expression. Differ-
ential gene expression (adj p,0.01) between periodontitis-affected and
healthy gingival tissues. The y axis corresponds to the log2 fold change
value (M value), and the x axis displays the mean expression value.
doi:10.1371/journal.pone.0046440.g005
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Table 4. Top 50 upregulated genes in periodontitis-affected tissue with Unigene entry.
Ensemble ID Gene symbol Description
Fold
change
Log2 fold
change p value
ENSG00000188596 C12orf63 chromosome 12 open reading frame 63 69,15 6,11 9,54e-06
ENSG00000132704 FCRL2 Fc receptor-like 2 30,36 4,92 1,39e-10
ENSG00000143297 FCRL5 Fc receptor-like 5 25,24 4,66 5,24e-30
ENSG00000116748 AMPD1 adenosine monophosphate deaminase 1
(isoform M)
24,97 4,64 5,58e-05
ENSG00000187323 DCC deleted in colorectal carcinoma 20,69 4,37 2,37e-09
ENSG00000137265 IRF4 interferon regulatory factor 4 20,10 4,33 1,50e-32
ENSG00000167077 MEI1 meiosis inhibitor 1 16,77 4,07 3,24e-16
ENSG00000101194 SLC17A9 solute carrier family 17, member 9 14,40 3,85 2,04e-14
ENSG00000122188 LAX1 lymphocyte transmembrane adaptor 1 14,28 3,84 3,83e-20
ENSG00000110777 POU2AF1 POU class 2 associating factor 1 14,12 3,82 9,81e-26
ENSG00000124256 ZBP1 Z-DNA binding protein 1 13,76 3,78 1,60e-14
ENSG00000170476 MGC29506 hypothetical protein MGC29506 13,33 3,74 1,20e-21
ENSG00000132185 FCRLA Fc receptor-like A 12,18 3,61 2,47e-11
ENSG00000012223 LTF lactotransferrin 12,09 3,61 8,54e-22
ENSG00000137673 MMP7 matrix metallopeptidase 7 (matrilysin, uterine) 11,37 3,51 8,33e-18
ENSG00000163534 FCRL1 Fc receptor-like 1 11,14 3,48 1,54e-05
ENSG00000177455 CD19 CD19 molecule 11,12 3,48 2,13e-08
ENSG00000061656 SPAG4 sperm associated antigen 4 11,09 3,47 1,62e-10
ENSG00000121895 TMEM156 transmembrane protein 156 11,00 3,46 2,35e-08
ENSG00000015413 DPEP1 dipeptidase 1 (renal) 10,93 3,45 8,81e-06
ENSG00000048462 TNFRSF17 tumor necrosis factor receptor superfamily,
member 17
10,43 3,38 2,71e-08
ENSG00000169962 TAS1R3 taste receptor, type 1, member 3 10,42 3,38 2,28e-06
ENSG00000102096 PIM2 pim-2 oncogene 10,09 3,34 2,43e-23
ENSG00000183508 FAM46C family with sequence similarity 46, member C 9,94 3,31 2,19e-24
ENSG00000168081 PNOC prepronociceptin 9,75 3,29 1,83e-07
ENSG00000099958 DERL3 Der1-like domain family, member 3 9,45 3,24 2,26e-16
ENSG00000105369 CD79A CD79a molecule, immunoglobulin-associated alpha 9,43 3,24 1,36e-18
ENSG00000189233 C8orf80 chromosome 8 open reading frame 80 9,03 3,17 2,42e-07
ENSG00000004468 CD38 CD38 molecule 8,75 3,13 7,57e-10
ENSG00000153789 FAM92B family with sequence similarity 92, member B 8,21 3,04 2,95e-05
ENSG00000143603 KCNN3 potassium intermediate/small conductance calcium-activated
channel, subfamily N, member 3
7,86 2,98 3,81e-07
ENSG00000007129 CEACAM21 carcinoembryonic antigen-related cell adhesion molecule 21 7,48 2,90 1,94e-05
ENSG00000170866 LILRA3 leukocyte immunoglobulin-like receptor, subfamily A
(without TM domain), member 3
7,45 2,90 0,000111577
ENSG00000129988 LBP lipopolysaccharide binding protein 7,33 2,87 7,78e-08
ENSG00000118308 LRMP lymphoid-restricted membrane protein 7,24 2,86 7,08e-09
ENSG00000139193 CD27 CD27 molecule 7,21 2,85 4,63e-13
ENSG00000073849 ST6GAL1 ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 7,11 2,83 4,37e-20
ENSG00000177272 KCNA3 potassium voltage-gated channel, shaker-related subfamily,
member 3
7,07 2,82 4,64e-08
ENSG00000108405 P2RX1 purinergic receptor P2X, ligand-gated ion channel, 1 6,81 2,77 3,18e-05
ENSG00000026751 SLAMF7 SLAM family member 7 6,64 2,73 2,05e-16
ENSG00000124772 CPNE5 copine V 6,47 2,69 5,14e-10
ENSG00000132465 IGJ immunoglobulin J polypeptide, linker protein for immunoglobulin
alpha and mu polypeptides
6,41 2,68 6,97e-21
ENSG00000122224 LY9 lymphocyte antigen 9 6,39 2,68 1,71e-06
ENSG00000007312 CD79B CD79b molecule, immunoglobulin-associated beta 6,28 2,65 1,89e-07
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change and p value. We investigated whether there were any
available reports on the involvement of these genes in periodontitis
or other chronic inflammatory conditions. Among the top 50
upregulated genes, we identified a number of candidate genes,
which were not previously demonstrated to be involved in
periodontitis but have been shown to be associated with other
chronic conditions such as rheumatoid arthritis (RA). These
candidate genes included FCRL5, adenosine monophosphate
deaminase 1 (AMPD1), CCL18, tumor-necrosis factor receptor
superfamily 17 (TNFRSF17) and leukocyte immunoglobin-like
receptor, subfamily A (without TM domain) member 3 (LILRA3),
and IRF4 which has shown to be involved in chronic inflamma-
tory diseases such as RA and inflammatory bowel disease (IBD),
(Table 5).
The protein expression of IRF4 and CCL18 in
periodontitis-affected tissue
The expression of two of the top 50 differentially upregulated
genes, IRF4 and CCL18 where further investigated at the protein
level in gingival tissue samples from five additional patients with
periodontitis. Immunohistochemical analysis showed that the
transcription factor IRF4 and the chemokine CCL18 were
expressed at the protein level in gingival tissue from patients with
periodontitis (Fig. 7). IRF4 protein was expressed in cells including
fibroblasts and inflammatory cells in the gingival connective tissue,
as shown by morphology. For the chemokine CCL18, cellular
staining of fibroblasts and inflammatory cells was observed, as well
as some diffuse extracellular staining, consistent with chemokine
secretion.
Discussion
This study provides a novel quantitative comprehensive
mapping of gene expression in gingival tissues from patients
diagnosed with periodontitis, using RNA-Seq.
We first confirmed that the degree of inflammation was higher
in periodontitis-affected gingival tissue compared to healthy tissues
obtained from the same individual. Our results were based on
immunohistological staining of CD3 positive cells, and further
verified by RNA-Seq quantification of gene expression of the
established inflammatory markers IL-1b, IL-6, IL-8, TNFa,
RANTES and MCP-1. These inflammatory mediators have
previously been reported to be elevated in patients with
periodontitis [25,26,27].
Next, we performed unsupervised clustering of the gingival
tissues to get an overview of the data generated from the RNA-Seq
analysis. Cluster analysis revealed that the majority of periodon-
titis-affected clustered together and the majority of the healthy
gingival tissues also clustered together, which is in line with our
results regarding inflammation in the tissues. The degree of
inflammation, rather than the individual, seemed to affect the
clustering, indicating a common gene expression profile for
periodontitis. Our results, based on the gene expression pattern
of the inflammatory markers (IL-1b, IL-6, IL-8, TNFa, RANTES
and MCP-1) and the immunohistochemical evaluation, confirmed
Table 5. Selected upregulated genes identified in periodontitis and involved in other chronic inflammatory diseases.
Ensemble ID Gene symbol Description
Fold
change
Log2 fold
change p value
Involvement in other
diseases
ENSG00000143297 FCRL5 Fc receptor-like 5 25.24 4.66 5.98e-27 Rheumatoid arthritis (RA)
ENSG00000116748 AMPD1 adenosine monophosphate deaminase 1 24.97 4.64 0.0046 Rheumatoid arthritis (RA)
ENSG00000137265 IRF4 interferon regulatory factor 4 20.10 4.33 2.31e-29 Inflammatory Bowel Disease
(IBD)
ENSG00000048462 TNFRSF17 tumor necrosis factor receptor
superfamily, member 17
10.43 3.38 4.80e-06 Rheumatoid arthritis (RA)
ENSG00000170866 LILRA3 leukocyte immunoglobulin-like
receptor, subfamily A
(without TM domain), member 3
7.45 2.90 0.008037 Rheumatoid arthritis (RA)
ENSG00000006074 CCL18 chemokine (C-C motif) ligand 18
(pulmonary and
activation-regulated
6.00 2.59 1.22e-07 Rheumatoid arthritis (RA)
doi:10.1371/journal.pone.0046440.t005
Table 4. Cont.
Ensemble ID Gene symbol Description
Fold
change
Log2 fold
change p value
ENSG00000134873 CLDN10 claudin 10 6,17 2,63 2,82e-06
ENSG00000172578 KLHL6 kelch-like 6 (Drosophila) 6,16 2,62 1,98e-11
ENSG00000196549 MME membrane metallo-endopeptidase 6,01 2,59 2,29e-16
ENSG00000006074 CCL18 chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) 6,00 2,59 5,68e-10
ENSG00000173432 SAA1 serum amyloid A1 5,91 2,56 7,97e-10
ENSG00000159618 GPR114 G protein-coupled receptor 114 5,89 2,56 1,29e-05
doi:10.1371/journal.pone.0046440.t004
Gene Expression in Periodontitis
PLOS ONE | www.plosone.org 9 September 2012 | Volume 7 | Issue 9 | e46440
that the inflammation in periodontitis involves elevated levels of
locally produced cytokines in the periodontium, as has been
previously demonstrated [28]. However, cluster analysis revealed
that three of the patients (patient no. 6, 7 and 2) deviated from the
clustering pattern. For example, the healthy gingival tissue
collected from patient 6 clustered with the periodontitis-affected
tissue, which could be due to moderate inflammatory infiltration
(H&E score 2) observed in the healthy gingival tissue. The
clustering pattern in tissue from patient 7, where the healthy and
diseased gingival tissue also clustered together, could be partly
explained by the patient’s history of osteoarthritis, which is a
disease associated with elevated levels of circulating proinflamma-
tory cytokines IL-6 and TNFa [29]. The cluster pattern for patient
2 differed from the rest of the patient group, which could be
related to this patient undergoing investigation for the inflamma-
tory disease sarcoidosis, and in turn might affect the systemic
inflammatory response. Previous studies report that oral manifes-
tations of sarcoidosis include aggressive destruction of the
periodontium with rapid periodontal bone loss [30,31,32]. One
of these studies also emphasizes the importance of patients
diagnosed with sarcoidosis to be evaluated for other systemic
involvements [31]. Thus, regarding our clustering pattern, it
cannot be ruled out that general health differences might have
some effect on the final outcome. However, the comparison of the
gene expression profiles of all individuals should minimize
potential interfering signals originating from single individuals
affected with other diseases.
Our RNA-Seq analysis, investigating the gene expression profile
in the gingival tissues showed that the genes were differentially
distributed between healthy and periodontitis-affected samples.
Enrichment analysis among uniquely expressed genes in the
periodontitis-affected tissues showed regulated pathways indicative
of inflammation, such as cytokine signaling, chemokine signaling
and the JAK-STAT signaling pathway. Several cytokines such as
interleukins, which are involved in periodontits, signal through the
JAK-STAT signaling pathway [33]. On the other hand, in the
healthy biopsies, pathways were indicative of non-inflammatory
processes that may be involved in the maintenance of the healthy
gingival tissue. Future studies should also include investigation of
genes within these pathways, which may contribute to under-
standing, prevention and treatment of periodontitis.
Differential gene expression analyses of periodontitis-affected vs.
healthy gingival tissues showed the majority of differentially
expressed genes to be upregulated in the periodontitis-affected
tissues. Furthermore, GO enrichment analysis among these
differentially expressed genes demonstrated that most of these
genes were involved in immune and inflammatory processes. This
is in line with the increased inflammatory response in the tissue,
and also in accordance with our previous microarray studies on
inflammatory-stimulated cell cultures reporting that gene expres-
sion profiles of TNFa-stimulated cells show an induction of
inflammatory genes [34,35].
Up to date, RNA-Seq studies aimed to identify new genes
involved in the pathogenesis of periodontits have not been
reported. One ab initio study by Covani et al. [36] identified genes
with potential roles in periodontitis, some of which have not
previously been associated with the disease. However, the protein
expression of these genes in periodontitis-affected tissues has not
been confirmed. In our study we aimed to identify genes involved
in the pathogenesis of periodontitis. Therefore, we further
searched through the differentially expressed genes, focusing on
the top 50 upregulated genes. Two of these 50 upregulated genes,
IRF4 and CCL18, were also detected at the protein level in
periodontitis affected-tissues, supporting these genes as novel finds
in the pathogenesis of periodontitis. Furthermore, these two
selected genes have been reported to be involved in other chronic
inflammatory diseases such as RA. The transcription factor, IRF4,
has been demonstrated to be involved in T-cell-dependent chronic
inflammatory diseases such as IBD [37]. Mudter et al. 2011
reported a correlation between mRNA levels of IRF4 and
production of cytokines such as IL-6 and IL-17 in the inflamed
colon from patients with IBD, indicating that IRF4 is involved in
the regulation of chronic mucosal inflammation [37]. In addition,
the gene for CCL18 was upregulated in periodontitis-affected
Figure 7. Immunohistochemical stainings of IRF4 and CCL18 in the connective tissue of periodontitis-affected gingival sections. A.
Immunohistochemical staining of IRF4. B. Immunohistochemical staining of CCL18.
doi:10.1371/journal.pone.0046440.g007
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gingival tissues. This chemokine, expressed by macrophages,
monocytes and dendritic cells, has been demonstrated to be
increased in synovial tissue of RA patients [38]. It has also been
suggested that blockage of CCL18 expression by anti-TNF-a
antibodies identifies CCL18 as an additional target for anti-TNF-a
therapy in patients with RA [39,40]. Studies are currently ongoing
to investigate the expression of candidate genes novel for
periodontitis in a larger cohort of patients with periodontitis and
healthy controls, to be able to evaluate their impact and to further
explore the possible therapeutic targeting of these genes. In
addition, future studies will also be performed investigating the
biological significance of the down-regulated genes in periodon-
titis.
In conclusion, we demonstrate for the first time, using RNA-seq,
profile analysis of periodontitis revealing site-specific local
variation in gene expression profiles of periodontitis-affected and
healthy tissues obtained from patients diagnosed with periodon-
titis. Furthermore, we have identified differentially expressed novel
genes in gingival tissue of periodontitis. Our findings provide a first
step towards a quantitative comprehensive insight into the
transcriptome of gingival tissue from patients with periodontitis,
to enable identification of possible diagnostic markers of
periodontitis as well as potential therapeutic targets.
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Abstract 
Background: The chronic inflammatory disease periodontitis is characterized by 
destruction of periodontal tissue, and involves a complex network of cells, inflammatory 
mediators and signaling pathways. Despite extensive research, the complete picture of the 
disease is still not known. Our aim is to improve the current understanding of periodontitis, to 
identify candidate genes for the disease, as well as to validate their protein expression in 
healthy and periodontitis tissue as potential biomarkers for periodontitis. 
Results: A total of 124 non-smoking subjects, 62 with periodontitis (mean age 64 ± 11) and 
62 healthy controls (mean age 56 ± 16) were included in the study. RNA-sequencing (RNA-
seq) analysis was performed using RNA extracted from gingival tissue biopsies. For 
assessment of the degree of inflammation, histological and immunohistochemical stainings 
were performed using H&E, anti-CD20 and anti-CD68 antibodies. The degree of 
inflammatory cell infiltration, evaluated in the gingival biopsies, was significantly higher in 
tissue obtained from patients with periodontitis compared to controls. The whole 
transcriptome analysis obtained by RNA-seq identified 22810 protein coding genes. Analyses 
of differentially expressed genes showed 665 upregulated and 633 downregulated genes in the 
periodontitis group. Furthermore, the categories immune- and defense response were the most 
significantly enriched biological processes among upregulated genes, whereas terms related to 
extracellular matrix/structure organization, collagen fibril organization, skeletal system 
development and skin/ectoderm/epidermis development were most significantly enriched 
among the downregulated genes. We identified two novel genes that were upregulated in 
periodontitis, Mucin 4 (MUC4) and matrix metalloproteinase 7 (MMP7). These genes were 
further confirmed at protein level in 20 gingival tissue biopsies from patients with 
periodontitis and 20 healthy controls.  
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Conclusions: This study reveals a comprehensive molecular profile of periodontitis, which 
contributes to a deeper understanding of the disease. Novel genes related to periodontitis were 
identified and the top two upregulated genes, MUC4 and MMP7, were also confirmed at 
protein level. This may lead to development of diagnostic biomarkers and therapeutic targets 
for periodontitis, which have the possibility to be applied in a clinical setting in the future.  
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Introduction 
Periodontitis is a chronic inflammatory disease characterized by tissue and bone 
destruction, which ultimately leads to tooth-loss. The disease is initiated when oral pathogens 
gain access to the gingival tissue and stimulate a host immune and inflammatory response. In 
susceptible individuals, inflammation fails to resolve and evolves into a chronic state, which 
causes destruction of the tooth-supporting structures including the gingival tissue and the 
underlying alveolar bone. The individual susceptibility for the disease is a result of the 
interactions between multiple genes and environmental factors, such as smoking or stress [1]. 
The hallmarks of periodontitis focus on host inflammatory events, including the release 
and activation of inflammatory mediators and cytokines such as interleukins (ILs) and tumor 
necrosis factor α (TNFα), as well as proteolytic enzymes, such as matrix metalloproteinases 
(MMPs). The chronic inflammatory process in the gingival tissue is also characterized by 
infiltration of inflammatory cell subsets, such as cytotoxic T lymphocytes, B lymphocytes, 
and macrophages [2,3]. Studies have investigated the levels of IL1β, TNFα and prostaglandin 
E2 (PGE2) in gingival crevicular fluid (GCF), a serum and local-tissue exudate that provides 
an accurate representation of tissue and serum concentrations of inflammatory mediators [4]. 
These studies showed that IL1β, TNFα and PGE2 levels were increased in GCF collected 
from periodontitis sites compared with clinically healthy sites [5,6]. In addition, the 
proteolytic enzymes MMPs, especially MMP2, MMP8 and MMP9 have been associated with 
periodontitis at protein level, in gingival tissues as well as in GCF and saliva [7-10]. 
Regarding the gingival tissue transcriptome in patients with periodontal disease, several 
studies have been performed. Demmer et al. [11] compared transcriptome from healthy and 
diseased papillae from patients with periodontitis. The genes identified to be upregulated in 
periodontitis were associated with apoptosis, antimicrobial humoral response, antigen 
presentation, regulation of metabolic processes, signal transduction and angiogenesis. Becker 
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et al. [12] showed apoptosis and proliferation processes to be most upregulated in 
periodontitis compared to healthy controls. Another study, focusing on inflammatory related 
genes, observed differences regarding gene expression involved in tissue damage and repair in 
periodontal tissues before and after periodontal treatment [13], while Offenbacher et al. [14] 
identified immune response genes as the most dominant expression pathway during induction 
and resolution of experimental gingivitis. The above-mentioned studies used microarray 
technology for the transcriptome profiling of periodontitis. Studies comparing RNA-seq 
versus microarray have shown RNA-seq to have higher sensitivity, wider dynamic range and 
lower technical variation than microarrays [15-17]. Our group has previously used RNA-seq 
to identify differentially expressed genes when comparing periodontitis and healthy gingival 
tissue obtained from the same patient. The results from the study showed that the upregulated 
genes were mainly indicative of immune and inflammatory responses [18].  
Despite previous studies on periodontitis, the complete picture of the disease is still not 
understood. In this study, we therefore aim to map the gene expression pattern in 
periodontitis. Because of the advantages of RNA-seq compared to microarrays, we will use 
RNA-seq, and, include a large cohort of participants consisting of patients with periodontitis 
and healthy subjects to enhance the power of detection of differentially expressed genes. 
Additionally, we aim to validate the identified differentially expressed genes at the protein 
level in gingival tissue biopsies from patients with periodontitis as well as healthy tissues in 
order to find potential biomarkers and future therapeutic targets for periodontitis.  
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Methods 
Ethics Statement 
The study was performed in accordance with the Declaration of Helsinki and the current 
legislation in Sweden and after approval from the Karolinska Institutet Ethical Research 
Board. The collection of human gingival tissue samples and the experimental procedures for 
the study was approved by the Regional Ethics Board in Stockholm, and informed consent 
was obtained from all participants. 
Subjects and collection of gingival biopsies 
A total number of 144 participants, 71 patients with periodontitis and 73 controls with no 
signs of periodontitis were included in the study. Patients that were included in the 
periodontitis group demonstrated a tooth site with a probing depth ≥ 6 mm, clinical 
attachment level ≥ 5 mm, as well as bleeding on probing. Subjects in the healthy control 
group showed no signs of periodontal disease, which was defined as sites with no 
gingival/periodontal inflammation, a probing depth ≤ 3.0 mm, a clinical attachment level ≤ 
3.5 mm, and no bleeding on probing. The healthy controls were all undergoing implant 
surgery due to tooth loss for other reasons e.g. caries, accidents etc. giving us a possibility to 
harvest a biopsy at the same time. Two gingival biopsies of similar size were harvested from 
the same site from each subject. One of the biopsies was stored in RNA Later (Applied 
Biosystems, USA) overnight at 4°C and thereafter kept at -80˚C for subsequent RNA 
isolation. The second biopsy was formalin fixed (4% neutral buffered formalin) and paraffin 
embedded for histological and immunohistochemical analysis. 
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Hematoxylin-Eosin staining 
Gingival biopsies were formalin fixed (4% neutral buffered formalin) and paraffin-
embedded. Serial sections (4µm thick) were deparaffinized and stained with Hematoxylin-
Eosin (H&E) for histological observations. The degree of inflammatory cell infiltration in the 
gingival tissues was evaluated by three blinded observers, using a relative scale from 0 to 3, 
where 0 = no evidence of inflammatory infiltration, 1 = slight inflammatory infiltration, 2 = 
moderate inflammatory infiltration and 3 = severe inflammatory infiltration. Z scores were 
calculated for each evaluation and the mean Z scores were reported for both groups. 
Immunohistochemical staining for CD20, CD68, MUC4 and MMP7 in gingival tissue 
Gingival tissues were pre-heated for 1 h at 60°C followed by deparaffinization. After an 
antigen retrieval procedure, using Dako Target Retrieval-solution for CD20, CD68 and 
MMP7 (Dako Sweden AB), and 10 mM Sodium Citrate, 0.05% Tween 20 (pH 6.0) for 
MUC4, sections were blocked in 1% H2O2 in phosphate buffer saline (PBS)-Saponin for 60 
min in room temperature (RT). Subsequently, tissue sections were further incubated with 3 % 
bovine serum albumin for 30 min at RT. The expression of CD20 was investigated using 
CD20 mouse monoclonal antibody (diluted at 1:100) from Leica Biosystems, (Stockholm, 
Sweden), the expression of CD68 with mouse monoclonal antibody (diluted at 1:50) from 
Dako (Stockholm, Sweden). As for the expression of MUC4 and MMP7, MUC4 monoclonal 
mouse antibody and MMP7 monoclonal mouse antibody were used, both at the dilution 1:100 
(Abcam, Cambridge, England). After incubation over night at 4°C with primary antibodies, 
sections were blocked with 1% normal goat serum for 15 min, and thereafter incubated with a 
horse radish peroxidase conjugated secondary polyclonal anti-mouse antibody (Dako Sweden 
AB, Stockholm, Sweden) for 40 min at RT in the dark. Afterwards, the Avidin-Biotin 
Complex solution (Vector laboratories, Burlingame, CA, US) was applied, for 40 min at RT 
in the dark. Further, sections were washed with PBS and the peroxidase activity was 
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visualized. Finally, the slides were dehydrated, mounted, and photographed using a light 
microscope. In parallel to each immunohistochemical staining, IgG was also used as a 
negative control, following the same protocol as for the antibodies used simultaneously 
(CD20, CD68, MUC4 or MMP7). The degree of MMP7 positive cells in epithelium and 
connective tissue was evaluated by three blinded observers, using a relative scale from 0 to 3. 
Z scores were calculated for each evaluation and the mean Z scores were reported. MUC4, 
CD20 and CD68 stained tissues were evaluated with whether there were positive cells or not 
in the tissue. The results from the periodontitis and healthy group were compared using 
Fisher’s exact test.  
RNA extraction 
RNA was extracted from the 144 biopsies using Qiagen RNeasy kit (VWR, Stockholm, 
Sweden). The quality of the extracted RNA was analyzed using the RNA 6000 NanoLabChip 
Kit of the Bioanalyzer system from Agilent Technologies (Santa Clara, CA, USA). Samples 
with RIN < 7 and a yield < 0.4 µg were excluded from further analysis, resulting in 123 
remaining samples of which 65 were from patients with periodontitis and 64 were from 
healthy controls. The resulting mean RIN value was 8.8 for the periodontitis group and 8.9 for 
the healthy control group.  
Library preparation and sequencing 
RNA libraries were prepared for sequencing using TruSeq Stranded mRNA Sample prep 
kit with 96 dual indexes (Illumina, CA, USA) according to the manufacturer’s instructions 
with the following changes: The protocols were automated using an Agilent NGS workstation 
(Agilent, CA, USA) using purification steps as described in Lundin et al [19] and Borgström 
et al [20]. The samples were clustered on cBot and sequenced on HiSeq 2500 according to the 
manufacturer's instructions. Demultiplexing and conversion was performed using CASAVA 
v1.8.2. (Illumina, CA, USA) and the quality scale used was Sanger / phred33 / Illumina 1.8+. 
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The runs generated an average of 44.3 million paired-end reads per sample, of which on 
average 81% mapped to the human genome. Five samples failed sequencing quality control 
and were excluded from further analysis, resulting in 124 remaining samples, of which 62 
were from patients with periodontitis and 62 were from healthy controls. 
Sequence read alignment and analysis 
The paired-end sequencing reads were aligned to the human genome assembly, build 
GRCh37/hg19, with STAR version 2.3.1o using standard parameters [21]. The aligned reads 
were used to count the number of reads per gene with HTSeq version 0.6.1, with standard 
parameters except for –s reverse [22]. Mapping statistics were calculated from numbers 
obtained by running bam_stat.py included in rseqc version 2.3.6 on bamfiles.  
PCA and OPLS-DA  
The read counts generated by HTSeq were used to perform principal component analysis 
(PCA) and orthogonal projections to latent structures discriminant analysis (OPLS-DA) by 
means of partial least squares. PCA was performed in R version 3.1.0 using the prcomp 
function. The PCA model was based on the 500 most variable genes after adjustment of raw 
counts by trimmed mean of M-values (TMM) scaling implemented in the 
Bioconductor/edgeR package [25] followed by transformation into log2 counts per million. 
For the PCA that was used to investigate the variation within the dataset with respect to the 
samples’ degree of inflammation, one patient was excluded since the degree of inflammation 
was missing due to the lack of second biopsy. The software used for the OPLS-DA model and 
S-plot was Simca 13.0.3 (Umetrics, Umeå, Sweden). Data was log transformed and unit 
variance scaled before the OPLS-DA and the model complexity was estimated according to 
cross-validation. For the S-plot, pareto-scaling was used instead of unit variance scaling. 
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Differential expression analysis 
The R/Bioconductor package samr version 2.0 [23] was used to normalize data and call 
differential expression based on the read counts generated by HTSeq. Genes were considered 
to be significantly differentially expressed between the two conditions at a False Discovery 
Rate (FDR) < 0.01. The q-value, obtained when calling differential expression through 
SAMSeq in the samr package, describes the p-values adjusted to correct the errors arising 
from multiple testing, using an FDR approach as described by Storey et al. [28]. To get 
additional information about the identified genes, gene names and descriptions were retrieved 
through the R/Bioconductor package biomaRt [24] via the Ensembl ID:s outputted in the list 
with differentially expressed genes, obtained using samr. A few gene names and descriptions 
were not available through biomaRt, and those were instead manually fetched from 
www.ensembl.org, via their Ensembl ID:s.  
GO category analysis 
The Database for Annotation, Visualization and Integrated Discovery (DAVID) [26] was 
used to perform gene functional annotation clustering of the upregulated and downregulated 
genes. Homo sapiens was used as background and the “GOTERM_BP_FAT” option selected. 
Default parameters were used when analyzing the functional annotation clustering. 
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Results 
Subject characteristics 
A total number of 124 participants, 62 patients with periodontitis and 62 healthy subjects, 
were included in the study. The characteristics of the study participants are demonstrated in 
Table 1. The gender distribution was similar in the periodontitis (33/29, females/males) and 
healthy control group (37/25, females/males). The mean age was 64 ± 11 for the periodontitis 
group and 56 ± 16 for the healthy controls. The clinical status obtained from all the 
participants showed that the probing depth, used to diagnose periodontal disease, was higher 
for the periodontitis group (8 mm) than the healthy control group (≤3 mm). Bleeding on 
probing, a widely used criterion to diagnose gingival inflammation [27], was more frequent in 
the periodontitis group, 79% (49 of 62), compared to the healthy control group, 21% (13 of 
62). The medical history and use of medications for each subject was also recorded and is 
displayed in Table 1. None of the subjects used nicotine or nicotine-replacement medications. 
Degree of inflammation and expression of CD20 and CD68 in gingival tissue biopsies 
For assessment of the degree of gingival inflammation, histological stainings were 
performed in all biopsies from 124 participants using H&E. Figures 1A and 1B show 
representative histological staining with H&E of gingival tissue from patients with 
periodontitis and healthy controls. The analyses, based on evaluation of inflammatory cell 
infiltration in gingival tissues by three blinded observers, showed significantly (P < 0.01) 
higher degree of inflammation in tissues from the periodontitis group (mean Z score 0.23; 
95% confidence interval [CI]: 0.03 to 0.43) compared to the control group (mean Z score -
0.24; 95% CI: -0.47 to -0.01) (Table 2). Immunohistochemical staining revealed a 
significantly (P < 0.01) higher expression of CD20 and CD68 in gingival connective tissue 
from patients with periodontitis than healthy subjects. Figures 1C-F demonstrates 
representative sections expressing CD20 and CD68 in gingival tissue obtained from patients 
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with periodontitis (1C and 1E) and healthy controls (1D and 1F). CD20 was expressed in 85% 
(17/20) of biopsies from periodontitis patients, and 40% (8/20) of biopsies from controls 
(Table 3). Similarly, the CD68 staining showed a significant (P < 0.05) difference between 
periodontitis and healthy controls, where 85% (17/20) of biopsies from periodontitis patients 
and 45% (9/20) of biopsies from controls showed expression of CD68 positive cell infiltration 
in the gingival connective tissue (Table 3).  
Multivariate analysis of periodontitis and healthy controls based on gene expression 
data 
In order to identify causes of variation and potential outliers or biases within the dataset, an 
unsupervised PCA model was created based on the gene expression data. The PCA model 
revealed that the largest variation in the dataset, the first principal component (PC1), 
explained 40% of the variance within the dataset and the second principal component (PC2) 
explained 15%. The PCA resulted in the samples aligning along PC1 according to their degree 
of inflammation, which is shown in Figure 2A. PC2 showed a tendency to separate the 
samples into periodontitis and healthy controls, which is visualized in Figure 2B.  
Furthermore, a supervised approach was applied to the dataset in order to identify which 
genes were responsible for the most pronounced differences between the two groups. An 
OPLS-DA model was therefore constructed after classification into periodontitis and healthy 
controls. A model with one predictive component and two orthogonal components was 
obtained, which successfully separated the samples into two groups along the first predictive 
component (Figure 3A). The degree of variation, the R2 value, was 0.629 and the model’s 
predictive ability, the Q2 value, was 0.304 resulting in significant differences between the two 
groups. Additionally, an OPLS-DA model was used to create an S-plot in order to identify 
potential biomarkers (Figure 3B). The magnitude of the contribution of each gene to the 
separation in the OPLS-DA model (p[1]) was plotted against the significance of that gene’s 
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variation (p[corr]). The genes contributing most to the classification into periodontitis, with 
highest significance, were MUC4 and MMP7.  
Differential gene expression and GO category enrichment analysis 
The RNA-seq analysis identified 22810 protein-coding genes. Differential expression 
analysis between the periodontitis and healthy control tissues revealed 1298 differentially 
expressed genes of which 665 were upregulated (supplementary data), and 633 downregulated 
(supplementary data) in periodontitis (with the q-value, an adjusted p-value, of 0.01). The 
upregulated and downregulated genes were used to identify enriched biological processes, 
using the functional annotation tool DAVID. The functional annotation clustering tool was 
used to cluster related groups as well as to order the clusters according to their significance, 
determined by the enrichment (EASE) scores. The three functional annotation clusters with 
the highest significance among upregulated genes included terms related to defense 
response/inflammatory response, response to wounding, apoptosis/cell death, and regulation 
of apoptosis/cell death (Figure 4A). The biological processes associated with downregulated 
genes included terms related to extracellular matrix/structure organization, collagen fibril 
organization, skeletal system development and skin/ectoderm/epidermis development (Figure 
4B). The two most upregulated genes in periodontitis compared to healthy gingival tissue 
were MUC4 and MMP7. 
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Expression of MUC4 and MMP7 in gingival tissue of patients with periodontitis and 
healthy controls 
The normalized counts for MUC4 and MMP7 in periodontitis tissue and healthy controls 
are visualized in Figure 5A and D. Because these genes were the two most upregulated genes, 
immunohistochemical stainings were performed to confirm and verify the expression of 
MUC4 and MMP7 at protein level. Staining analyses were performed in 20 biopsies from the 
periodontitis group and 20 from healthy controls. Stainings showed positive expression of 
MUC4 in gingival epithelial cells in 18 patients of 20 (90 %), giving a significant difference 
with a p-value < 0.001 (Figure 5 and Table 3). In the gingival tissues from healthy controls, 
only 2 biopsies of 20 (10 %) showed expression of MUC4 in gingival epithelial cells (Table 
4). Immunostaining experiments of MMP7 showed that the protein was significantly (p-value 
<0.01) higher expressed in connective tissue from patients with periodontitis than in healthy 
controls (Figure 5 and Table 4). The mean Z score of MMP7 expression was 0.40 (95% CI: 
0.02; 0.78) for the periodontitis group and -0.41 (95% CI: -0.78; -0.04) for controls (Figure 5 
and Table 4). However, there was no significant difference in expression of MMP7 in the 
epithelium of gingiva from periodontitis and healthy controls. The mean Z score in epithelial 
tissue was 0.16 (95% CI: -0.28; 0.6) for periodontitis and -0.05 (95% CI: -0.45; 0.35) for 
corresponding controls (Figure 5 and Table 4).   
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Discussion 
In this study, we have analyzed the whole transcriptome in periodontitis, using RNA-seq, 
and we propose two novel genes, MUC4 and MMP7, as potential biomarkers. We revealed 
these genes to be the most upregulated genes in periodontitis and they were additionally 
verified to be overexpressed also at protein level. Further, significant differences between 
periodontitis and healthy controls regarding overall gene expression patterns were identified 
as well as a number of differentially expressed genes between periodontitis and healthy 
controls. Notably, several of these genes were novel findings not earlier associated with 
periodontitis. Among these genes, biological processes related to inflammatory response and 
apoptosis were identified to be upregulated, while processes related to extracellular matrix 
organization and bone development were downregulated. The findings presented here provide 
a map over the transcriptome in periodontitis and reveal genes previously unknown to be 
involved in periodontitis.  
RNA-seq is a powerful tool for addressing the pathophysiology of complex diseases, such 
as periodontitis. Previous studies investigating the transcriptome in periodontitis have mainly 
used microarray technology. Our group has in a previous study used RNA-seq to study the 
transcriptome in gingival tissue from patients with periodontitis, and in the current study we 
included a larger cohort of gingival tissue biopsies from 124 periodontitis and healthy controls 
to get a better detection power of differentially expressed genes [29]. Given that no study has 
had access to high-quality RNA-seq data from a cohort of this size, including both patients 
with periodontitis and healthy controls, the results from this study provide an important 
addition to the field of periodontal disease.  
Inflammation is the main characteristic of periodontitis and we could confirm that the 
degree of inflammation was higher in the periodontitis group than in the healthy control 
group. In agreement with previous findings [30], we confirmed that the periodontitis group 
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exhibited a higher degree of inflammatory cell infiltration in gingival tissue compared to the 
healthy group, which is consistent with the disease characteristics. Additionally, the 
expression of CD20 and CD68, markers specific for B cell and macrophages, was higher in 
gingival connective tissue from patients with periodontitis than in healthy controls. However, 
we could, through the multivariate analysis, identify gene expression patterns separated from 
inflammation. Although the degree of inflammation was identified to be higher in the 
periodontitis group than in the control group, the results from the multivariate analysis 
indicate that there are gene expression patterns separating periodontitis from healthy tissue 
irrespective of the degree of inflammation. The genes contributing most to the gene 
expression pattern in periodontitis; MUC4 and MMP7, were reappearing in the univariate 
differential gene expression analysis, further supporting their significance in the pathogenesis 
of periodontitis.  
Our GO term analysis revealed regulation of the biological processes immune response, 
inflammatory response, as well as processes indicative of apoptosis among the upregulated 
genes. These processes have also been reported by other groups [11,13,14,18]. The 
upregulation of the immune response processes was in agreement with results obtained from 
the histological stainings confirming a higher degree of inflammation in gingival tissue from 
patients with periodontitis. Among downregulated genes, biological processes associated with 
extracellular matrix organization, bone development and collagen fibril organization 
appeared. The downregulation of the above-mentioned processes is in line with the main 
characteristics of periodontitis, which is destruction of supporting connective tissue and 
alveolar bone.  
The most upregulated genes in periodontitis were revealed to be MUC4 and MMP7. Our 
study is the first to demonstrate the overexpression of MUC4 and MMP7 in periodontitis. 
These genes might have potential as biomarkers for the early detection of periodontitis and 
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studies will be performed investigating the levels of MUC4 and MMP7 in saliva and GCF 
from patients with periodontitis and healthy controls, for a possible use in a clinical setting. 
Gingival tissue consists of epithelium and connective tissue and comprises a heterogeneous 
mix of different cell types including epithelial cells, fibroblasts and infiltrating cells. This may 
have some limitations on the interpretation of the transcriptome analysis, because the 
observed gene expression originates from a mix of these cell types. Gingival tissue biopsies 
may have different number of cells, resulting in skewed gene expression patterns, a question 
that has been raised also by other groups [11]. Future studies should therefore focus on 
investigating the gene expression while also taking into account the heterogeneity in the 
tissues. Studies are ongoing using a novel RNA-seq method where the gene expression in 
each individual cell in a tissue section can be investigated simultaneously. This approach 
enables the association of gene expression to the cell type of interest, overcoming the 
limitations with RNA-seq of whole biopsies of heterogeneous tissues, such as gingival tissue.  
In conclusion, this study provides better insights into the pathogenesis of periodontitis. We 
have revealed significant differences between the transcriptome profiles of periodontitis and 
healthy gingival tissues, as well as novel genes that may serve as potential biomarkers for the 
disease. This knowledge may lead us to new insights in the development of diagnostic 
biomarkers and therapeutics for periodontitis. 
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Figure legends 
Figure 1. Histological and immunohistological staining of gingival biopsies obtained 
from patients with periodontitis and healthy controls. Representative histological stainings 
with H&E in gingival tissue from a patient with periodontitis (A) and a healthy control (B). 
Representative immunohistological staining in gingival tissue with B cell marker CD20 and 
macrophage marker CD68 in gingival tissue obtained from a patient with periodontitis and (C 
and E, respectively) and a healthy control (D and F, respectively). Scale bars = 50µm. 
Figure 2. PCA score plots of RNA-seq samples show the largest and second largest 
variation in the dataset. The two first principal components (PC1 and PC2) are plotted on 
the x- and y-axis. (A) PCA score plot of periodontitis tissues and healthy control tissues 
shows that the largest variation in the data set is caused by the degree of inflammation. Data 
points representing the samples are colored according to their degree of inflammation (green 
= 0, yellow = 1, orange = 2, red = 3). (B) The same PCA plot with data points color-coded red 
(periodontitis) and blue (healthy controls), showing a separation in principal component 2 
between periodontitis tissues and healthy controls.  
Figure 3. Score scatter plot from OPLS-DA modeling of the gene expression data. (A) 
The OPLS-DA score plot showing the between group variation, predictive component, t(1), 
and within-group variation, orthogonal component, to(1) of periodontitis gingival tissues (red) 
and healthy controls (blue), with respect to gene expression. (B) S-plot from the OPLS-DA 
data showing the magnitude of each gene’s contribution to the separation, p(1) against the 
reliability of each gene, p(corr). The genes contributing the most to the periodontitis group are 
highlighted in red and are, MMP7 and MUC4.  
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Figure 4. GO categories enriched among upregulated and downregulated genes. 
Biological processes upregulated (A) and downregulated (B) in periodontitis were identified 
using the annotation tool DAVID. Related biological processes were clustered using the 
functional annotation clustering tool. The upregulated processes with the highest enrichment 
scores included terms related to defense response/inflammatory response, response to 
wounding, apoptosis/cell death, and regulation of apoptosis/cell death. The biological 
processes with the highest enrichment scores among downregulated genes included terms 
related to extracellular matrix/structure organization, collagen fibril organization, skeletal 
system development and skin/ectoderm/epidermis development 
Figure 5. mRNA and protein expression of MUC4 and MMP7 in gingival tissue biopsies 
from periodontitis tissues and healthy controls. (A) Boxplot demonstrating the normalized 
number of transcripts of MUC4 in periodontitis and healthy control tissues. (B) 
Representative staining for MUC4 in gingival epithelium from a patient with periodontitis and 
(C) a healthy control. (D) Normalized number of transcripts of MMP7 in periodontitis tissues 
and healthy tissues. (E) Staining for MMP7 in gingival epithelium from one representative 
patient with periodontitis and (F) a healthy control. Scale bars = 50µm. 
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Table 1. The characteristics of the study participants, periodontitis and healthy controls. 
 Periodontitis Healthy controls 
Patients (n) 62 62 
Gender (f/m) 33/29 37/25 
Mean age (min-max) 64 (38-83) 56 (18-78) 
Mean probing depth (mm) 8  3  
Bleeding on probing  (n) 49/62 13/62 
Other diseases 16 4 
Asthma 1 1 
Chronic obstructive pulmonary disease 1 0 
Diabetes type-2 2 0 
Hypertension 12 1 
Parkinson’s disease 0 1 
Rheumatoid arthritis 0 1 
Medication (n) 13 2 
Nonsteroidal anti-inflammatory drugs 3 1 
Asthma medicine 3 0 
Simvastatin 5 1 
Diabetes medicine 2 0 
 
 
 
 
Table 2. The degree of inflammation by H&E in the gingival connective tissue biopsies obtained 
from patients (n=62) with periodontitis and healthy controls (n=61). 
 
Degree of inflammation  (0-3)a 
 
0 
 
1 
 
2 
 
3 
 
Mean Z score (95% CI) 
Periodontitis (n) 4 17 19 22 0.23 (0.03; 0.43) 
Healthy (n) 11 21 17 12 -0.24 (-0.47; -0.01) 
a0 = no evidence of inflammatory infiltration, 1 = slight inflammatory infiltration, 2 = moderate inflammatory 
infiltration and 3 = severe inflammatory infiltration. 
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Table 3. Expression of CD20, CD68 and MUC4 in gingival tissue from patients with periodontitis 
(n=20) and healthy controls (n=20). 
Periodontitis Healthy controls 
Subject CD20 CD68 MUC4 Subject CD20 CD68 MUC4 
1 + + - 21 - - - 
2 - - + 22 - - - 
3 + + + 23 + + - 
4 + + + 24 + + - 
5 + + + 25 - - - 
6 - + + 26 + + - 
7 + + + 27 - - + 
8 + - + 28 + + + 
9 + + + 29 - - - 
10 - - - 30 + + - 
11 + + + 31 - - - 
12 + + + 32 + + - 
13 + + + 33 - - - 
14 + + + 34 + + - 
15 + + + 35 + + - 
16 + + + 36 - - - 
17 + + + 37 - - - 
18 + + + 38 - - - 
19 + + + 39 - - - 
20 + + + 40 - - - 
(+) evidence of CD20, CD68 or MUC4 expression, (-) no evidence of CD20, CD68 or MUC4 expression. 
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Table 4. Expression of MMP7 in epithelium and connective tissue from patients with 
periodontitis (n=20) and healthy controls (n=20). 
Periodontitis Healthy controls 
Subject Epithelium (0-3)a Connective tissue (0-3)a Subject Epithelium (0-3)a Connective tissue (0-3)a 
1 2 2 21 1 1 
2 0 1 22 2 2 
3 1 1 23 1 1 
4 1 1 24 3 2 
5 1 1 25 1 1 
6 2 3 26 0 0 
7 3 3 27 0 0 
8 0 0 28 3 3 
9 1 1 29 1 1 
10 0 0 30 0 0 
11 1 1 31 2 0 
12 3 3 32 0 0 
13 2 2 33 2 2 
14 2 3 34 0 0 
15 2 2 35 1 1 
16 3 3 36 1 1 
17 3 3 37 1 0 
18 3 3 38 3 3 
19 2 2 39 2 2 
20 3 3 40 2 2 
Mean Z 
score 
(95% CI) 
0.16 (0.28; 0.6)b 0.40 (0.02; 0.78)c 
Mean Z 
score 
(95% CI) 
-0.05 (-0.45; 
0.35)b -0.41 (-0.78; -0.04)
c 
a0 = no evidence of inflammatory infiltration, 1 = slight inflammatory infiltration, 2 = moderate inflammatory 
infiltration and 3 = severe inflammatory infiltration. bSignificance of difference between periodontitis and 
healthy controls, p = 0.49. cSignificance of difference between periodontitis and healthy controls, p = 4.8 * 10-3. 
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